DE10219433A1 - Sunscreen preparations using acrylonitrile derivatives - Google Patents
Sunscreen preparations using acrylonitrile derivativesInfo
- Publication number
- DE10219433A1 DE10219433A1 DE2002119433 DE10219433A DE10219433A1 DE 10219433 A1 DE10219433 A1 DE 10219433A1 DE 2002119433 DE2002119433 DE 2002119433 DE 10219433 A DE10219433 A DE 10219433A DE 10219433 A1 DE10219433 A1 DE 10219433A1
- Authority
- DE
- Germany
- Prior art keywords
- dimethyl
- formula
- dihydro
- methylene
- oxopentanenitrile
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 70
- 150000008360 acrylonitriles Chemical class 0.000 title claims abstract description 27
- 230000000475 sunscreen effect Effects 0.000 title claims description 14
- 239000000516 sunscreening agent Substances 0.000 title claims description 14
- 239000002537 cosmetic Substances 0.000 claims abstract description 58
- 230000005855 radiation Effects 0.000 claims abstract description 13
- -1 amino, hydroxy, acetoxy, carboxy Chemical group 0.000 claims description 104
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 claims description 68
- 239000006096 absorbing agent Substances 0.000 claims description 49
- 150000001875 compounds Chemical class 0.000 claims description 39
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 29
- 230000004224 protection Effects 0.000 claims description 25
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 claims description 22
- 239000003921 oil Substances 0.000 claims description 22
- 239000000049 pigment Substances 0.000 claims description 17
- 150000002148 esters Chemical class 0.000 claims description 15
- 239000001257 hydrogen Substances 0.000 claims description 15
- 229910052739 hydrogen Inorganic materials 0.000 claims description 15
- 239000004904 UV filter Substances 0.000 claims description 14
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 14
- 125000000217 alkyl group Chemical group 0.000 claims description 13
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 13
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 12
- 125000004432 carbon atom Chemical group C* 0.000 claims description 12
- 229910052760 oxygen Inorganic materials 0.000 claims description 12
- 239000001301 oxygen Substances 0.000 claims description 12
- 239000006071 cream Substances 0.000 claims description 10
- 229920000642 polymer Polymers 0.000 claims description 9
- 125000006710 (C2-C12) alkenyl group Chemical group 0.000 claims description 8
- 125000006711 (C2-C12) alkynyl group Chemical group 0.000 claims description 8
- 239000003963 antioxidant agent Substances 0.000 claims description 8
- NZZIMKJIVMHWJC-UHFFFAOYSA-N dibenzoylmethane Chemical compound C=1C=CC=CC=1C(=O)CC(=O)C1=CC=CC=C1 NZZIMKJIVMHWJC-UHFFFAOYSA-N 0.000 claims description 8
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 claims description 7
- 239000006210 lotion Substances 0.000 claims description 7
- 229920001296 polysiloxane Polymers 0.000 claims description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 6
- 125000001072 heteroaryl group Chemical group 0.000 claims description 6
- 229910044991 metal oxide Inorganic materials 0.000 claims description 6
- 150000004706 metal oxides Chemical class 0.000 claims description 6
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims description 6
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 6
- 125000001424 substituent group Chemical group 0.000 claims description 6
- 230000002195 synergetic effect Effects 0.000 claims description 6
- 239000004753 textile Substances 0.000 claims description 6
- 125000003545 alkoxy group Chemical group 0.000 claims description 5
- 125000003118 aryl group Chemical group 0.000 claims description 5
- 239000000839 emulsion Substances 0.000 claims description 5
- 235000013336 milk Nutrition 0.000 claims description 5
- 239000008267 milk Substances 0.000 claims description 5
- 210000004080 milk Anatomy 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 125000004642 (C1-C12) alkoxy group Chemical group 0.000 claims description 4
- 125000003358 C2-C20 alkenyl group Chemical group 0.000 claims description 4
- 125000000304 alkynyl group Chemical group 0.000 claims description 4
- 125000004104 aryloxy group Chemical group 0.000 claims description 4
- 239000004305 biphenyl Substances 0.000 claims description 4
- 239000007854 depigmenting agent Substances 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 4
- 239000003995 emulsifying agent Substances 0.000 claims description 4
- 239000000499 gel Substances 0.000 claims description 4
- 239000001023 inorganic pigment Substances 0.000 claims description 4
- AFDXODALSZRGIH-UHFFFAOYSA-N p-coumaric acid methyl ether Natural products COC1=CC=C(C=CC(O)=O)C=C1 AFDXODALSZRGIH-UHFFFAOYSA-N 0.000 claims description 4
- 230000000176 photostabilization Effects 0.000 claims description 4
- 239000007921 spray Substances 0.000 claims description 4
- 239000002562 thickening agent Substances 0.000 claims description 4
- QMIBDVOQOZDSEN-UHFFFAOYSA-N 2-phenylbenzimidazole-2-sulfonic acid Chemical compound N1=C2C=CC=CC2=NC1(S(=O)(=O)O)C1=CC=CC=C1 QMIBDVOQOZDSEN-UHFFFAOYSA-N 0.000 claims description 3
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical class NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 claims description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 3
- 150000008366 benzophenones Chemical class 0.000 claims description 3
- 239000008139 complexing agent Substances 0.000 claims description 3
- 230000000254 damaging effect Effects 0.000 claims description 3
- 239000003925 fat Substances 0.000 claims description 3
- 239000002304 perfume Substances 0.000 claims description 3
- 229920003023 plastic Polymers 0.000 claims description 3
- 239000004033 plastic Substances 0.000 claims description 3
- 239000011701 zinc Substances 0.000 claims description 3
- 229910052725 zinc Inorganic materials 0.000 claims description 3
- HEOCBCNFKCOKBX-RELGSGGGSA-N (1s,2e,4r)-4,7,7-trimethyl-2-[(4-methylphenyl)methylidene]bicyclo[2.2.1]heptan-3-one Chemical compound C1=CC(C)=CC=C1\C=C/1C(=O)[C@]2(C)CC[C@H]\1C2(C)C HEOCBCNFKCOKBX-RELGSGGGSA-N 0.000 claims description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical class C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims description 2
- VMSCVFABAMNEFP-UHFFFAOYSA-N 2-(2,3-dihydroindol-1-ylmethylidene)-4,4-dimethyl-3-oxopentanenitrile Chemical compound C1=CC=C2N(C=C(C(=O)C(C)(C)C)C#N)CCC2=C1 VMSCVFABAMNEFP-UHFFFAOYSA-N 0.000 claims description 2
- LPGNBVWGYBKQEZ-UHFFFAOYSA-N 2-[(2,3-dimethyl-2,3-dihydroindol-1-yl)methylidene]-4,4-dimethyl-3-oxopentanenitrile Chemical compound C1=CC=C2N(C=C(C#N)C(=O)C(C)(C)C)C(C)C(C)C2=C1 LPGNBVWGYBKQEZ-UHFFFAOYSA-N 0.000 claims description 2
- YFAFHJJKWFXVCL-UHFFFAOYSA-N 2-[(2,5-dimethyl-2,3-dihydroindol-1-yl)methylidene]-4,4-dimethyl-3-oxopentanenitrile Chemical compound CC1=CC=C2N(C=C(C#N)C(=O)C(C)(C)C)C(C)CC2=C1 YFAFHJJKWFXVCL-UHFFFAOYSA-N 0.000 claims description 2
- HRTRZIRXIIWXOM-UHFFFAOYSA-N 2-[(5-methoxy-2,3,3-trimethyl-2h-indol-1-yl)methylidene]-4,4-dimethyl-3-oxopentanenitrile Chemical compound COC1=CC=C2N(C=C(C#N)C(=O)C(C)(C)C)C(C)C(C)(C)C2=C1 HRTRZIRXIIWXOM-UHFFFAOYSA-N 0.000 claims description 2
- AIOSNDJQIAHZFT-UHFFFAOYSA-N 2-[(5-methoxy-2,3-dihydroindol-1-yl)methylidene]-4,4-dimethyl-3-oxopentanenitrile Chemical compound COC1=CC=C2N(C=C(C#N)C(=O)C(C)(C)C)CCC2=C1 AIOSNDJQIAHZFT-UHFFFAOYSA-N 0.000 claims description 2
- AIYQXPBDYMGPFU-UHFFFAOYSA-N 2-[(5-methoxy-2-methyl-2,3-dihydroindol-1-yl)methylidene]-4,4-dimethyl-3-oxopentanenitrile Chemical compound COC1=CC=C2N(C=C(C#N)C(=O)C(C)(C)C)C(C)CC2=C1 AIYQXPBDYMGPFU-UHFFFAOYSA-N 0.000 claims description 2
- ULKFPXJCGHRWCU-UHFFFAOYSA-N 2-[1-(3,4-dihydro-2h-quinolin-1-yl)ethylidene]-4,4-dimethyl-3-oxopentanenitrile Chemical compound C1=CC=C2N(C(C)=C(C#N)C(=O)C(C)(C)C)CCCC2=C1 ULKFPXJCGHRWCU-UHFFFAOYSA-N 0.000 claims description 2
- IHENTRJRPOYCCO-UHFFFAOYSA-N 4,4-dimethyl-2-[(2-methyl-2,3-dihydroindol-1-yl)methylidene]-3-oxopentanenitrile Chemical compound C1=CC=C2N(C=C(C#N)C(=O)C(C)(C)C)C(C)CC2=C1 IHENTRJRPOYCCO-UHFFFAOYSA-N 0.000 claims description 2
- ZIOYBZIWUKNWKR-UHFFFAOYSA-N 4,4-dimethyl-2-[1-(2-methyl-2,3-dihydroindol-1-yl)ethylidene]-3-oxopentanenitrile Chemical compound C1=CC=C2N(C(C)=C(C#N)C(=O)C(C)(C)C)C(C)CC2=C1 ZIOYBZIWUKNWKR-UHFFFAOYSA-N 0.000 claims description 2
- FWOFXOIZSGOVTG-UHFFFAOYSA-N 4,4-dimethyl-3-oxo-2-[(2,3,3-trimethyl-2h-indol-1-yl)methylidene]pentanenitrile Chemical compound C1=CC=C2C(C)(C)C(C)N(C=C(C#N)C(=O)C(C)(C)C)C2=C1 FWOFXOIZSGOVTG-UHFFFAOYSA-N 0.000 claims description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 2
- 239000000443 aerosol Substances 0.000 claims description 2
- 125000001931 aliphatic group Chemical group 0.000 claims description 2
- 125000004429 atom Chemical group 0.000 claims description 2
- 239000012965 benzophenone Substances 0.000 claims description 2
- 150000001565 benzotriazoles Chemical class 0.000 claims description 2
- 239000000975 dye Substances 0.000 claims description 2
- 229920001971 elastomer Polymers 0.000 claims description 2
- 229960004697 enzacamene Drugs 0.000 claims description 2
- 239000006260 foam Substances 0.000 claims description 2
- 229910052742 iron Inorganic materials 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 239000005022 packaging material Substances 0.000 claims description 2
- 239000003973 paint Substances 0.000 claims description 2
- 239000000419 plant extract Substances 0.000 claims description 2
- 239000003755 preservative agent Substances 0.000 claims description 2
- 239000005060 rubber Substances 0.000 claims description 2
- 150000004756 silanes Chemical class 0.000 claims description 2
- 239000010936 titanium Substances 0.000 claims description 2
- 229910052719 titanium Inorganic materials 0.000 claims description 2
- 150000003918 triazines Chemical class 0.000 claims description 2
- GBXQPDCOMJJCMJ-UHFFFAOYSA-M trimethyl-[6-(trimethylazaniumyl)hexyl]azanium;bromide Chemical compound [Br-].C[N+](C)(C)CCCCCC[N+](C)(C)C GBXQPDCOMJJCMJ-UHFFFAOYSA-M 0.000 claims description 2
- 239000002966 varnish Substances 0.000 claims description 2
- 229940088594 vitamin Drugs 0.000 claims description 2
- 229930003231 vitamin Natural products 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- 230000003711 photoprotective effect Effects 0.000 claims 2
- AFDXODALSZRGIH-QPJJXVBHSA-N (E)-3-(4-methoxyphenyl)prop-2-enoic acid Chemical compound COC1=CC=C(\C=C\C(O)=O)C=C1 AFDXODALSZRGIH-QPJJXVBHSA-N 0.000 claims 1
- CNXZMGRWEYQCOQ-UHFFFAOYSA-N 2-methoxy-3-phenylprop-2-enoic acid Chemical class COC(C(O)=O)=CC1=CC=CC=C1 CNXZMGRWEYQCOQ-UHFFFAOYSA-N 0.000 claims 1
- ISDGWTZFJKFKMO-UHFFFAOYSA-N 2-phenyl-1,3-dioxane-4,6-dione Chemical class O1C(=O)CC(=O)OC1C1=CC=CC=C1 ISDGWTZFJKFKMO-UHFFFAOYSA-N 0.000 claims 1
- 150000001556 benzimidazoles Chemical class 0.000 claims 1
- 235000010290 biphenyl Nutrition 0.000 claims 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N cinnamic acid Chemical class OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 claims 1
- 239000002826 coolant Substances 0.000 claims 1
- 239000003974 emollient agent Substances 0.000 claims 1
- 239000004519 grease Substances 0.000 claims 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims 1
- 150000003902 salicylic acid esters Chemical class 0.000 claims 1
- NJIVITWUGKPJII-UHFFFAOYSA-M sodium;2-[4-(4,6-disulfo-1h-benzimidazol-2-yl)phenyl]-6-sulfo-1h-benzimidazole-4-sulfonate Chemical compound [Na+].C1=C(S(O)(=O)=O)C=C2NC(C3=CC=C(C=C3)C3=NC4=C(C=C(C=C4N3)S(=O)(=O)O)S(O)(=O)=O)=NC2=C1S([O-])(=O)=O NJIVITWUGKPJII-UHFFFAOYSA-M 0.000 claims 1
- 239000000203 mixture Substances 0.000 description 26
- 238000003756 stirring Methods 0.000 description 23
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 22
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 20
- 235000019198 oils Nutrition 0.000 description 20
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 18
- 229960001679 octinoxate Drugs 0.000 description 18
- 235000019441 ethanol Nutrition 0.000 description 17
- 230000037072 sun protection Effects 0.000 description 17
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 16
- HEAHZSUCFKFERC-IWGRKNQJSA-N [(2e)-2-[[4-[(e)-[7,7-dimethyl-3-oxo-4-(sulfomethyl)-2-bicyclo[2.2.1]heptanylidene]methyl]phenyl]methylidene]-7,7-dimethyl-3-oxo-4-bicyclo[2.2.1]heptanyl]methanesulfonic acid Chemical group CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)\C2=C\C(C=C1)=CC=C1\C=C/1C(=O)C2(CS(O)(=O)=O)CCC\1C2(C)C HEAHZSUCFKFERC-IWGRKNQJSA-N 0.000 description 16
- 239000002253 acid Substances 0.000 description 14
- 150000003839 salts Chemical class 0.000 description 14
- 229910002012 Aerosil® Inorganic materials 0.000 description 13
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 229920002125 Sokalan® Polymers 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 12
- 239000004808 2-ethylhexylester Substances 0.000 description 11
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Natural products OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 239000011787 zinc oxide Substances 0.000 description 10
- 150000001298 alcohols Chemical class 0.000 description 8
- 235000014113 dietary fatty acids Nutrition 0.000 description 8
- 239000000194 fatty acid Substances 0.000 description 8
- 229930195729 fatty acid Natural products 0.000 description 8
- 235000011187 glycerol Nutrition 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 239000012071 phase Substances 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 7
- 235000006708 antioxidants Nutrition 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 7
- 229920002545 silicone oil Polymers 0.000 description 7
- DSSYKIVIOFKYAU-OIBJUYFYSA-N (S)-camphor Chemical compound C1C[C@]2(C)C(=O)C[C@H]1C2(C)C DSSYKIVIOFKYAU-OIBJUYFYSA-N 0.000 description 6
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 6
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 6
- LSHGMOIQPURPAK-UHFFFAOYSA-N 2-benzylidene-1,4,7,7-tetramethylbicyclo[2.2.1]heptan-3-one Chemical compound CC1(C)C(C2=O)(C)CCC1(C)C2=CC1=CC=CC=C1 LSHGMOIQPURPAK-UHFFFAOYSA-N 0.000 description 5
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 5
- 239000004380 Cholic acid Substances 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- DLAHAXOYRFRPFQ-UHFFFAOYSA-N dodecyl benzoate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1 DLAHAXOYRFRPFQ-UHFFFAOYSA-N 0.000 description 5
- 229940068171 ethyl hexyl salicylate Drugs 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 229920000058 polyacrylate Polymers 0.000 description 5
- 235000013772 propylene glycol Nutrition 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 229920006395 saturated elastomer Polymers 0.000 description 5
- 239000001993 wax Substances 0.000 description 5
- WAYINTBTZWQNSN-UHFFFAOYSA-N 11-methyldodecyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C WAYINTBTZWQNSN-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 4
- 229910010413 TiO 2 Inorganic materials 0.000 description 4
- 239000007983 Tris buffer Substances 0.000 description 4
- UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 229960004881 homosalate Drugs 0.000 description 4
- 230000002209 hydrophobic effect Effects 0.000 description 4
- QAOJADINKLMTRR-UHFFFAOYSA-N octan-3-yl 16-methylheptadecanoate Chemical compound CCCCCC(CC)OC(=O)CCCCCCCCCCCCCCC(C)C QAOJADINKLMTRR-UHFFFAOYSA-N 0.000 description 4
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 4
- 229960000601 octocrylene Drugs 0.000 description 4
- NPSJHQMIVNJLNN-UHFFFAOYSA-N 2-ethylhexyl 4-nitrobenzoate Chemical compound CCCCC(CC)COC(=O)C1=CC=C([N+]([O-])=O)C=C1 NPSJHQMIVNJLNN-UHFFFAOYSA-N 0.000 description 3
- MXZMACXOMZKYHJ-UHFFFAOYSA-N 4,4-dimethyl-3-oxopentanenitrile Chemical compound CC(C)(C)C(=O)CC#N MXZMACXOMZKYHJ-UHFFFAOYSA-N 0.000 description 3
- 108010087806 Carnosine Proteins 0.000 description 3
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 3
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 206010042496 Sunburn Diseases 0.000 description 3
- 230000006750 UV protection Effects 0.000 description 3
- WYWZRNAHINYAEF-AWEZNQCLSA-N [(2s)-2-ethylhexyl] 4-(dimethylamino)benzoate Chemical compound CCCC[C@H](CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-AWEZNQCLSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 229940086555 cyclomethicone Drugs 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 150000002191 fatty alcohols Chemical class 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 239000004611 light stabiliser Substances 0.000 description 3
- 229960002248 meradimate Drugs 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 3
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 3
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 3
- 229960001173 oxybenzone Drugs 0.000 description 3
- 229960002638 padimate o Drugs 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- 239000004408 titanium dioxide Substances 0.000 description 3
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- LBUJPTNKIBCYBY-UHFFFAOYSA-N 1,2,3,4-tetrahydroquinoline Chemical compound C1=CC=C2CCCNC2=C1 LBUJPTNKIBCYBY-UHFFFAOYSA-N 0.000 description 2
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- OIQXFRANQVWXJF-UHFFFAOYSA-N 2-benzylidene-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one Chemical compound CC1(C)C2CCC1(C)C(=O)C2=CC1=CC=CC=C1 OIQXFRANQVWXJF-UHFFFAOYSA-N 0.000 description 2
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 2
- LEEDMQGKBNGPDN-UHFFFAOYSA-N 2-methylnonadecane Chemical compound CCCCCCCCCCCCCCCCCC(C)C LEEDMQGKBNGPDN-UHFFFAOYSA-N 0.000 description 2
- ZSNLEVJATWJBLU-UHFFFAOYSA-N 2-tert-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(C(C)(C)C)(OC)C(=O)C1=CC=CC=C1 ZSNLEVJATWJBLU-UHFFFAOYSA-N 0.000 description 2
- DZAUWHJDUNRCTF-UHFFFAOYSA-N 3-(3,4-dihydroxyphenyl)propanoic acid Chemical compound OC(=O)CCC1=CC=C(O)C(O)=C1 DZAUWHJDUNRCTF-UHFFFAOYSA-N 0.000 description 2
- LUKNZSDCSDDKNC-UHFFFAOYSA-N 3-benzylidene-1,7,7-trimethylbicyclo[2.2.1]heptan-2-one methyl hydrogen sulfate Chemical compound COS(O)(=O)=O.CC1(C)C2CCC1(C)C(=O)C2=CC1=CC=CC=C1 LUKNZSDCSDDKNC-UHFFFAOYSA-N 0.000 description 2
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 2
- SJIDAAGFCNIAJP-UHFFFAOYSA-N 6-methylheptyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCC(C)C SJIDAAGFCNIAJP-UHFFFAOYSA-N 0.000 description 2
- QZCLKYGREBVARF-UHFFFAOYSA-N Acetyl tributyl citrate Chemical compound CCCCOC(=O)CC(C(=O)OCCCC)(OC(C)=O)CC(=O)OCCCC QZCLKYGREBVARF-UHFFFAOYSA-N 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N Decanoic acid Natural products CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- XTJFFFGAUHQWII-UHFFFAOYSA-N Dibutyl adipate Chemical compound CCCCOC(=O)CCCCC(=O)OCCCC XTJFFFGAUHQWII-UHFFFAOYSA-N 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N Salicylic acid Natural products OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- UBNYRXMKIIGMKK-UHFFFAOYSA-N amiloxate Chemical compound COC1=CC=C(C=CC(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-UHFFFAOYSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 229960004050 aminobenzoic acid Drugs 0.000 description 2
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- ISAOCJYIOMOJEB-UHFFFAOYSA-N benzoin Chemical compound C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 description 2
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 2
- 229940044199 carnosine Drugs 0.000 description 2
- 150000001746 carotenes Chemical class 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 229960002433 cysteine Drugs 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- BWUPRNSPZFPYEK-UHFFFAOYSA-N dichloro(diethyl)germane Chemical compound CC[Ge](Cl)(Cl)CC BWUPRNSPZFPYEK-UHFFFAOYSA-N 0.000 description 2
- BOLQJTPHPSDZHR-UHFFFAOYSA-N dihydroferulic acid Chemical compound COC1=CC(CCC(O)=O)=CC=C1O BOLQJTPHPSDZHR-UHFFFAOYSA-N 0.000 description 2
- 229940031578 diisopropyl adipate Drugs 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 2
- 235000001785 ferulic acid Nutrition 0.000 description 2
- 229940114124 ferulic acid Drugs 0.000 description 2
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- QRMZSPFSDQBLIX-UHFFFAOYSA-N homovanillic acid Chemical compound COC1=CC(CC(O)=O)=CC=C1O QRMZSPFSDQBLIX-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 2
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- SOXAGEOHPCXXIO-DVOMOZLQSA-N menthyl anthranilate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1N SOXAGEOHPCXXIO-DVOMOZLQSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 239000002777 nucleoside Substances 0.000 description 2
- 125000003835 nucleoside group Chemical group 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229940048845 polyglyceryl-3 diisostearate Drugs 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 2
- 239000005871 repellent Substances 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 2
- PCMORTLOPMLEFB-ONEGZZNKSA-N sinapic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-ONEGZZNKSA-N 0.000 description 2
- 230000037380 skin damage Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 235000019149 tocopherols Nutrition 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 2
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 2
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- WEAPVABOECTMGR-UHFFFAOYSA-N triethyl 2-acetyloxypropane-1,2,3-tricarboxylate Chemical compound CCOC(=O)CC(C(=O)OCC)(OC(C)=O)CC(=O)OCC WEAPVABOECTMGR-UHFFFAOYSA-N 0.000 description 2
- PYOKUURKVVELLB-UHFFFAOYSA-N trimethyl orthoformate Chemical compound COC(OC)OC PYOKUURKVVELLB-UHFFFAOYSA-N 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- DBSABEYSGXPBTA-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O DBSABEYSGXPBTA-RXSVEWSESA-N 0.000 description 1
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- OIQXFRANQVWXJF-QBFSEMIESA-N (2z)-2-benzylidene-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one Chemical compound CC1(C)C2CCC1(C)C(=O)\C2=C/C1=CC=CC=C1 OIQXFRANQVWXJF-QBFSEMIESA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- IZFHEQBZOYJLPK-SSDOTTSWSA-N (R)-dihydrolipoic acid Chemical compound OC(=O)CCCC[C@@H](S)CCS IZFHEQBZOYJLPK-SSDOTTSWSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- NKJOXAZJBOMXID-UHFFFAOYSA-N 1,1'-Oxybisoctane Chemical compound CCCCCCCCOCCCCCCCC NKJOXAZJBOMXID-UHFFFAOYSA-N 0.000 description 1
- NDQXKKFRNOPRDW-UHFFFAOYSA-N 1,1,1-triethoxyethane Chemical compound CCOC(C)(OCC)OCC NDQXKKFRNOPRDW-UHFFFAOYSA-N 0.000 description 1
- FGWYWKIOMUZSQF-UHFFFAOYSA-N 1,1,1-triethoxypropane Chemical compound CCOC(CC)(OCC)OCC FGWYWKIOMUZSQF-UHFFFAOYSA-N 0.000 description 1
- 125000005919 1,2,2-trimethylpropyl group Chemical group 0.000 description 1
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
- 125000005918 1,2-dimethylbutyl group Chemical group 0.000 description 1
- BTWNEJOURYOHME-UHFFFAOYSA-N 1,3-thiazol-2-ylhydrazine Chemical class NNC1=NC=CS1 BTWNEJOURYOHME-UHFFFAOYSA-N 0.000 description 1
- 150000005208 1,4-dihydroxybenzenes Chemical class 0.000 description 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N 1,4a-dimethyl-7-propan-2-yl-2,3,4,4b,5,6,10,10a-octahydrophenanthrene-1-carboxylic acid Chemical compound C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- 125000006218 1-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- OVYMWJFNQQOJBU-UHFFFAOYSA-N 1-octanoyloxypropan-2-yl octanoate Chemical compound CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC OVYMWJFNQQOJBU-UHFFFAOYSA-N 0.000 description 1
- IVWSGOOPQGMALJ-UHFFFAOYSA-N 2,3,3-trimethyl-1,2-dihydroindole Chemical compound C1=CC=C2C(C)(C)C(C)NC2=C1 IVWSGOOPQGMALJ-UHFFFAOYSA-N 0.000 description 1
- GJUXFTUISAQMQE-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-ethylhexanoate;2,3-dimethoxy-3-phenylprop-2-enoic acid Chemical compound CCCCC(CC)C(=O)OCC(O)CO.COC(C(O)=O)=C(OC)C1=CC=CC=C1 GJUXFTUISAQMQE-UHFFFAOYSA-N 0.000 description 1
- YEAYGXLRPMKZBP-UHFFFAOYSA-N 2-(2-hydroxyethylamino)ethanol;3-(4-methoxyphenyl)prop-2-enoic acid Chemical compound OCCNCCO.COC1=CC=C(C=CC(O)=O)C=C1 YEAYGXLRPMKZBP-UHFFFAOYSA-N 0.000 description 1
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical group COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- JPEAZAYOLNNTFK-UHFFFAOYSA-N 2-(3,4-dihydroxyphenyl)-2-hydroxyacetamide Chemical class NC(=O)C(O)C1=CC=C(O)C(O)=C1 JPEAZAYOLNNTFK-UHFFFAOYSA-N 0.000 description 1
- QRWRJDVVXAXGBT-UHFFFAOYSA-N 2-Methylindoline Chemical compound C1=CC=C2NC(C)CC2=C1 QRWRJDVVXAXGBT-UHFFFAOYSA-N 0.000 description 1
- KUPCCVYANAHYEX-UHFFFAOYSA-N 2-[(4-methoxyphenyl)methylidene]butanoic acid Chemical compound CCC(C(O)=O)=CC1=CC=C(OC)C=C1 KUPCCVYANAHYEX-UHFFFAOYSA-N 0.000 description 1
- UFXVNSSPBAMMNK-UHFFFAOYSA-N 2-[[4,6-bis(2-carboxyanilino)-1,3,5-triazin-2-yl]amino]benzoic acid Chemical compound OC(=O)C1=CC=CC=C1NC1=NC(NC=2C(=CC=CC=2)C(O)=O)=NC(NC=2C(=CC=CC=2)C(O)=O)=N1 UFXVNSSPBAMMNK-UHFFFAOYSA-N 0.000 description 1
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 description 1
- CZVOIAOPRGNENY-UHFFFAOYSA-N 2-butyloctyl 2-hydroxybenzoate Chemical compound CCCCCCC(CCCC)COC(=O)C1=CC=CC=C1O CZVOIAOPRGNENY-UHFFFAOYSA-N 0.000 description 1
- RRSYNAMOFATAOU-UHFFFAOYSA-N 2-cyano-3-(2-octan-3-ylphenyl)-3-phenylprop-2-enoic acid Chemical compound CCCCCC(CC)C1=CC=CC=C1C(=C(C#N)C(O)=O)C1=CC=CC=C1 RRSYNAMOFATAOU-UHFFFAOYSA-N 0.000 description 1
- IJVRPNIWWODHHA-UHFFFAOYSA-N 2-cyanoprop-2-enoic acid Chemical class OC(=O)C(=C)C#N IJVRPNIWWODHHA-UHFFFAOYSA-N 0.000 description 1
- NFIHXTUNNGIYRF-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCCC NFIHXTUNNGIYRF-UHFFFAOYSA-N 0.000 description 1
- 125000006176 2-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 1
- LWLRMRFJCCMNML-UHFFFAOYSA-N 2-ethylhexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(CC)CCCC LWLRMRFJCCMNML-UHFFFAOYSA-N 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- MWKPHOIHTLQZIY-UHFFFAOYSA-N 2-hexyldecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC MWKPHOIHTLQZIY-UHFFFAOYSA-N 0.000 description 1
- IQXWVZRMYFOEQO-UHFFFAOYSA-N 2-methyl-5-[(4,7,7-trimethyl-3-oxo-2-bicyclo[2.2.1]heptanylidene)methyl]benzenesulfonic acid Chemical compound C1=C(S(O)(=O)=O)C(C)=CC=C1C=C1C(=O)C2(C)CCC1C2(C)C IQXWVZRMYFOEQO-UHFFFAOYSA-N 0.000 description 1
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 1
- 125000005916 2-methylpentyl group Chemical group 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- RUDXBXPTJPNTSO-UHFFFAOYSA-N 2-octyldodecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC RUDXBXPTJPNTSO-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- ODJQKYXPKWQWNK-UHFFFAOYSA-N 3,3'-Thiobispropanoic acid Chemical compound OC(=O)CCSCCC(O)=O ODJQKYXPKWQWNK-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- AGNTUZCMJBTHOG-UHFFFAOYSA-N 3-[3-(2,3-dihydroxypropoxy)-2-hydroxypropoxy]propane-1,2-diol Chemical class OCC(O)COCC(O)COCC(O)CO AGNTUZCMJBTHOG-UHFFFAOYSA-N 0.000 description 1
- GXHFOIKNNVNFAS-UHFFFAOYSA-N 3-ethyl-2-hexoxybenzoic acid Chemical compound CCCCCCOC1=C(CC)C=CC=C1C(O)=O GXHFOIKNNVNFAS-UHFFFAOYSA-N 0.000 description 1
- 125000003542 3-methylbutan-2-yl group Chemical group [H]C([H])([H])C([H])(*)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- CERSVDLOCLTLAN-UHFFFAOYSA-N 3-methylbutyl 2-cyanoacetate Chemical compound CC(C)CCOC(=O)CC#N CERSVDLOCLTLAN-UHFFFAOYSA-N 0.000 description 1
- 125000005917 3-methylpentyl group Chemical group 0.000 description 1
- QJZYHAIUNVAGQP-UHFFFAOYSA-N 3-nitrobicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid Chemical compound C1C2C=CC1C(C(=O)O)C2(C(O)=O)[N+]([O-])=O QJZYHAIUNVAGQP-UHFFFAOYSA-N 0.000 description 1
- LFESLSYSZQYEIZ-UHFFFAOYSA-N 3-octanoyloxybutyl octanoate Chemical compound CCCCCCCC(=O)OCCC(C)OC(=O)CCCCCCC LFESLSYSZQYEIZ-UHFFFAOYSA-N 0.000 description 1
- BCNHLLBBAYKJAN-UHFFFAOYSA-N 4,4-dimethyl-2-[(5-methyl-2,3-dihydroindol-1-yl)methylidene]-3-oxopentanenitrile Chemical compound CC1=CC=C2N(C=C(C#N)C(=O)C(C)(C)C)CCC2=C1 BCNHLLBBAYKJAN-UHFFFAOYSA-N 0.000 description 1
- KKJKXQYVUVWWJP-UHFFFAOYSA-N 4-[(4,7,7-trimethyl-3-oxo-2-bicyclo[2.2.1]heptanylidene)methyl]benzenesulfonic acid Chemical compound CC1(C)C2CCC1(C)C(=O)C2=CC1=CC=C(S(O)(=O)=O)C=C1 KKJKXQYVUVWWJP-UHFFFAOYSA-N 0.000 description 1
- NGJJZCPADSICRI-UHFFFAOYSA-N 4-[[4,6-bis(4-carboxyanilino)-1,3,5-triazin-2-yl]amino]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1N=C(NC(=NC=1C=CC(=CC=1)C(O)=O)N1)NC1=NC1=CC=C(C(O)=O)C=C1 NGJJZCPADSICRI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- NSAOIAYLNQLPAZ-UHFFFAOYSA-N 4-hydroxy-5-(2-hydroxy-4-methoxy-5-sulfobenzoyl)-2-methoxybenzenesulfonic acid;sodium Chemical compound [Na].[Na].C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC(S(O)(=O)=O)=C(OC)C=C1O NSAOIAYLNQLPAZ-UHFFFAOYSA-N 0.000 description 1
- WHDIPFLMGHMXGP-UHFFFAOYSA-N 5-(aminomethyl)benzene-1,2,3-triol Chemical compound NCC1=CC(O)=C(O)C(O)=C1 WHDIPFLMGHMXGP-UHFFFAOYSA-N 0.000 description 1
- JPJCJVLMPPNLQB-UHFFFAOYSA-N 5-methoxy-2,3,3-trimethyl-1,2-dihydroindole Chemical compound COC1=CC=C2NC(C)C(C)(C)C2=C1 JPJCJVLMPPNLQB-UHFFFAOYSA-N 0.000 description 1
- YYDYAQAVAHKFJO-UHFFFAOYSA-N 5-methoxy-2,3-dihydro-1h-indole Chemical compound COC1=CC=C2NCCC2=C1 YYDYAQAVAHKFJO-UHFFFAOYSA-N 0.000 description 1
- AKUPYGILGNUOIG-UHFFFAOYSA-N 5-methoxy-4-phenyltriazine Chemical compound COC1=CN=NN=C1C1=CC=CC=C1 AKUPYGILGNUOIG-UHFFFAOYSA-N 0.000 description 1
- XUVVLJKRLAXOKZ-UHFFFAOYSA-N 7-methyloctyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCC(C)C XUVVLJKRLAXOKZ-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 229910002014 Aerosil® 130 Inorganic materials 0.000 description 1
- 229910002015 Aerosil® 150 Inorganic materials 0.000 description 1
- 229910002016 Aerosil® 200 Inorganic materials 0.000 description 1
- 229910002018 Aerosil® 300 Inorganic materials 0.000 description 1
- 229910002019 Aerosil® 380 Inorganic materials 0.000 description 1
- 229910018072 Al 2 O 3 Inorganic materials 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- HKIKAXXIWJHWLY-ZIIYPAMZSA-N Aloesin Chemical compound C=12OC(CC(=O)C)=CC(=O)C2=C(C)C=C(O)C=1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HKIKAXXIWJHWLY-ZIIYPAMZSA-N 0.000 description 1
- HKIKAXXIWJHWLY-QEVGBQTESA-N Aloesin Natural products O=C(CC=1Oc2c([C@H]3[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O3)c(O)cc(C)c2C(=O)C=1)C HKIKAXXIWJHWLY-QEVGBQTESA-N 0.000 description 1
- 108010085443 Anserine Proteins 0.000 description 1
- 244000139693 Arctostaphylos uva ursi Species 0.000 description 1
- 235000012871 Arctostaphylos uva ursi Nutrition 0.000 description 1
- XHVAWZZCDCWGBK-WYRLRVFGSA-M Aurothioglucose Chemical compound OC[C@H]1O[C@H](S[Au])[C@H](O)[C@@H](O)[C@@H]1O XHVAWZZCDCWGBK-WYRLRVFGSA-M 0.000 description 1
- 241000155630 Bembidion castor Species 0.000 description 1
- GWZYPXHJIZCRAJ-UHFFFAOYSA-N Biliverdin Natural products CC1=C(C=C)C(=C/C2=NC(=Cc3[nH]c(C=C/4NC(=O)C(=C4C)C=C)c(C)c3CCC(=O)O)C(=C2C)CCC(=O)O)NC1=O GWZYPXHJIZCRAJ-UHFFFAOYSA-N 0.000 description 1
- RCNSAJSGRJSBKK-NSQVQWHSSA-N Biliverdin IX Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(\C=C/2C(=C(C)C(=C/C=3C(=C(C=C)C(=O)N=3)C)/N\2)CCC(O)=O)N1 RCNSAJSGRJSBKK-NSQVQWHSSA-N 0.000 description 1
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 244000001582 Canarium odontophyllum Species 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- LAAPRQODJPXAHC-UHFFFAOYSA-N Coniferyl benzoate Natural products C1=C(O)C(OC)=CC(C=CCOC(=O)C=2C=CC=CC=2)=C1 LAAPRQODJPXAHC-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- GHKOFFNLGXMVNJ-UHFFFAOYSA-N Didodecyl thiobispropanoate Chemical compound CCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCC GHKOFFNLGXMVNJ-UHFFFAOYSA-N 0.000 description 1
- 239000003508 Dilauryl thiodipropionate Substances 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 239000002656 Distearyl thiodipropionate Substances 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 101100326757 Drosophila melanogaster Capr gene Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241001125671 Eretmochelys imbricata Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- SLRNWACWRVGMKD-UHFFFAOYSA-N L-anserine Natural products CN1C=NC(CC(NC(=O)CCN)C(O)=O)=C1 SLRNWACWRVGMKD-UHFFFAOYSA-N 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- WIWGXURDMPANAJ-UHFFFAOYSA-N Mono-Natrium-Salz Natural products S1C=C(COC(N)=O)C(C(O)=O)N2C(=O)C(OC)(NC(=O)CCCC(N)C(O)=O)C21 WIWGXURDMPANAJ-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 125000003047 N-acetyl group Chemical group 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- WYWZRNAHINYAEF-UHFFFAOYSA-N Padimate O Chemical compound CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 229920002396 Polyurea Polymers 0.000 description 1
- 241000210053 Potentilla elegans Species 0.000 description 1
- KNAHARQHSZJURB-UHFFFAOYSA-N Propylthiouracile Chemical compound CCCC1=CC(=O)NC(=S)N1 KNAHARQHSZJURB-UHFFFAOYSA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- RJFAYQIBOAGBLC-BYPYZUCNSA-N Selenium-L-methionine Chemical compound C[Se]CC[C@H](N)C(O)=O RJFAYQIBOAGBLC-BYPYZUCNSA-N 0.000 description 1
- RJFAYQIBOAGBLC-UHFFFAOYSA-N Selenomethionine Natural products C[Se]CCC(N)C(O)=O RJFAYQIBOAGBLC-UHFFFAOYSA-N 0.000 description 1
- 229910004298 SiO 2 Inorganic materials 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 206010040799 Skin atrophy Diseases 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical class [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 244000028419 Styrax benzoin Species 0.000 description 1
- 235000000126 Styrax benzoin Nutrition 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 235000008411 Sumatra benzointree Nutrition 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 239000003490 Thiodipropionic acid Substances 0.000 description 1
- 102000002933 Thioredoxin Human genes 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 239000012963 UV stabilizer Substances 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- CGQCWMIAEPEHNQ-UHFFFAOYSA-N Vanillylmandelic acid Chemical compound COC1=CC(C(O)C(O)=O)=CC=C1O CGQCWMIAEPEHNQ-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- GLLSGHWYBGERSE-UHFFFAOYSA-N [2-(hydroxymethoxy)phenyl]-phenylmethanone;sodium Chemical compound [Na].OCOC1=CC=CC=C1C(=O)C1=CC=CC=C1 GLLSGHWYBGERSE-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 150000001345 alkine derivatives Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229960002709 amiloxate Drugs 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021486 amorphous silicon dioxide Inorganic materials 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- MYYIAHXIVFADCU-QMMMGPOBSA-N anserine Chemical compound CN1C=NC=C1C[C@H](NC(=O)CC[NH3+])C([O-])=O MYYIAHXIVFADCU-QMMMGPOBSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940111133 antiinflammatory and antirheumatic drug oxicams Drugs 0.000 description 1
- 229940111131 antiinflammatory and antirheumatic product propionic acid derivative Drugs 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 125000003289 ascorbyl group Chemical class [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- 229940071097 ascorbyl phosphate Drugs 0.000 description 1
- 229960001799 aurothioglucose Drugs 0.000 description 1
- 229960005193 avobenzone Drugs 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- 235000012216 bentonite Nutrition 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960002130 benzoin Drugs 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- QBUVFDKTZJNUPP-UHFFFAOYSA-N biliverdin-IXalpha Natural products N1C(=O)C(C)=C(C=C)C1=CC1=C(C)C(CCC(O)=O)=C(C=C2C(=C(C)C(C=C3C(=C(C=C)C(=O)N3)C)=N2)CCC(O)=O)N1 QBUVFDKTZJNUPP-UHFFFAOYSA-N 0.000 description 1
- 230000000035 biogenic effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- UFVWHIGSVGIZRQ-UHFFFAOYSA-N bis(2-ethylhexyl) naphthalene-2,6-dicarboxylate Chemical compound C1=C(C(=O)OCC(CC)CCCC)C=CC2=CC(C(=O)OCC(CC)CCCC)=CC=C21 UFVWHIGSVGIZRQ-UHFFFAOYSA-N 0.000 description 1
- 239000012496 blank sample Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- ULBTUVJTXULMLP-UHFFFAOYSA-N butyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCC ULBTUVJTXULMLP-UHFFFAOYSA-N 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 1
- 229940114374 butylene glycol dicaprylate Drugs 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol group Chemical group [C@@H]1(CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)[C@H](C)CCCC(C)C HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 229940114081 cinnamate Drugs 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 229940071160 cocoate Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- LAAPRQODJPXAHC-AATRIKPKSA-N coniferyl benzoate Chemical compound C1=C(O)C(OC)=CC(\C=C\COC(=O)C=2C=CC=CC=2)=C1 LAAPRQODJPXAHC-AATRIKPKSA-N 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000008271 cosmetic emulsion Substances 0.000 description 1
- 239000008407 cosmetic solvent Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- OOTFVKOQINZBBF-UHFFFAOYSA-N cystamine Chemical compound CCSSCCN OOTFVKOQINZBBF-UHFFFAOYSA-N 0.000 description 1
- 229940099500 cystamine Drugs 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 229940000033 dermatological agent Drugs 0.000 description 1
- 239000003241 dermatological agent Substances 0.000 description 1
- 150000001983 dialkylethers Chemical class 0.000 description 1
- 229940100539 dibutyl adipate Drugs 0.000 description 1
- 150000001993 dienes Chemical class 0.000 description 1
- 235000019304 dilauryl thiodipropionate Nutrition 0.000 description 1
- CNHQWLUGXFIDAT-UHFFFAOYSA-N dioctyl 2-hydroxybutanedioate Chemical compound CCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCC CNHQWLUGXFIDAT-UHFFFAOYSA-N 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- LPUISHHNWLAJOV-UHFFFAOYSA-L disodium;5,6-disulfo-7-[2-(2,5,6,7-tetrasulfo-3h-benzimidazol-4-yl)phenyl]-1h-benzimidazole-2,4-disulfonate Chemical compound [Na+].[Na+].C=12NC(S(=O)(=O)O)=NC2=C(S(O)(=O)=O)C(S(O)(=O)=O)=C(S(O)(=O)=O)C=1C1=CC=CC=C1C1=C(S(O)(=O)=O)C(S(O)(=O)=O)=C(S([O-])(=O)=O)C2=C1NC(S([O-])(=O)=O)=N2 LPUISHHNWLAJOV-UHFFFAOYSA-L 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- PWWSSIYVTQUJQQ-UHFFFAOYSA-N distearyl thiodipropionate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCCCCCCCC PWWSSIYVTQUJQQ-UHFFFAOYSA-N 0.000 description 1
- 235000019305 distearyl thiodipropionate Nutrition 0.000 description 1
- 229960003747 ecamsule Drugs 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- ZIUSEGSNTOUIPT-UHFFFAOYSA-N ethyl 2-cyanoacetate Chemical compound CCOC(=O)CC#N ZIUSEGSNTOUIPT-UHFFFAOYSA-N 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000002468 fat body Anatomy 0.000 description 1
- 239000004872 foam stabilizing agent Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 125000005908 glyceryl ester group Chemical group 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 229940065115 grapefruit extract Drugs 0.000 description 1
- 235000019382 gum benzoic Nutrition 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- HTDJPCNNEPUOOQ-UHFFFAOYSA-N hexamethylcyclotrisiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O1 HTDJPCNNEPUOOQ-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000004021 humic acid Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 229940078546 isoeicosane Drugs 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940089456 isopropyl stearate Drugs 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- CUONGYYJJVDODC-UHFFFAOYSA-N malononitrile Chemical compound N#CCC#N CUONGYYJJVDODC-UHFFFAOYSA-N 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 239000012184 mineral wax Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 150000005673 monoalkenes Chemical class 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GQEZCXVZFLOKMC-UHFFFAOYSA-N n-alpha-hexadecene Natural products CCCCCCCCCCCCCCC=C GQEZCXVZFLOKMC-UHFFFAOYSA-N 0.000 description 1
- VTWKXBJHBHYJBI-UHFFFAOYSA-N n-benzylidenehydroxylamine Chemical class ON=CC1=CC=CC=C1 VTWKXBJHBHYJBI-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 1
- HCZKYJDFEPMADG-UHFFFAOYSA-N nordihydroguaiaretic acid Chemical compound C=1C=C(O)C(O)=CC=1CC(C)C(C)CC1=CC=C(O)C(O)=C1 HCZKYJDFEPMADG-UHFFFAOYSA-N 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- QUAMTGJKVDWJEQ-UHFFFAOYSA-N octabenzone Natural products OC1=CC(OCCCCCCCC)=CC=C1C(=O)C1=CC=CC=C1 QUAMTGJKVDWJEQ-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- AXIUTKTZNZMMSI-UHFFFAOYSA-N octan-3-yl 2-cyano-3,3-diphenylprop-2-enoate Chemical compound C=1C=CC=CC=1C(=C(C#N)C(=O)OC(CC)CCCCC)C1=CC=CC=C1 AXIUTKTZNZMMSI-UHFFFAOYSA-N 0.000 description 1
- VBGBCSDVBCZDGB-UHFFFAOYSA-N octan-3-yl 2-cyanoacetate Chemical compound CCCCCC(CC)OC(=O)CC#N VBGBCSDVBCZDGB-UHFFFAOYSA-N 0.000 description 1
- KTAQORMASMTUAT-UHFFFAOYSA-N octan-3-yl 4-aminobenzoate Chemical compound CCCCCC(CC)OC(=O)C1=CC=C(N)C=C1 KTAQORMASMTUAT-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- YAGMLECKUBJRNO-UHFFFAOYSA-N octyl 4-(dimethylamino)benzoate Chemical compound CCCCCCCCOC(=O)C1=CC=C(N(C)C)C=C1 YAGMLECKUBJRNO-UHFFFAOYSA-N 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940098695 palmitic acid Drugs 0.000 description 1
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 231100000760 phototoxic Toxicity 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229920003216 poly(methylphenylsiloxane) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000008389 polyethoxylated castor oil Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 229940100518 polyglyceryl-4 isostearate Drugs 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- PZQSQRCNMZGWFT-QXMHVHEDSA-N propan-2-yl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC(C)C PZQSQRCNMZGWFT-QXMHVHEDSA-N 0.000 description 1
- ZPWFUIUNWDIYCJ-UHFFFAOYSA-N propan-2-yl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(C)C ZPWFUIUNWDIYCJ-UHFFFAOYSA-N 0.000 description 1
- 150000005599 propionic acid derivatives Chemical class 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960002662 propylthiouracil Drugs 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 150000003217 pyrazoles Chemical class 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002940 repellent Effects 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 235000012045 salad Nutrition 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 125000003548 sec-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229960002718 selenomethionine Drugs 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 231100000152 severe skin burn Toxicity 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- LIVNPJMFVYWSIS-UHFFFAOYSA-N silicon monoxide Chemical class [Si-]#[O+] LIVNPJMFVYWSIS-UHFFFAOYSA-N 0.000 description 1
- 229910052814 silicon oxide Inorganic materials 0.000 description 1
- PCMORTLOPMLEFB-UHFFFAOYSA-N sinapinic acid Natural products COC1=CC(C=CC(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-UHFFFAOYSA-N 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- RPACBEVZENYWOL-XFULWGLBSA-M sodium;(2r)-2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate Chemical compound [Na+].C=1C=C(Cl)C=CC=1OCCCCCC[C@]1(C(=O)[O-])CO1 RPACBEVZENYWOL-XFULWGLBSA-M 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 150000001629 stilbenes Chemical class 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 125000005555 sulfoximide group Chemical group 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229960000368 sulisobenzone Drugs 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- PZTAGFCBNDBBFZ-UHFFFAOYSA-N tert-butyl 2-(hydroxymethyl)piperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCCCC1CO PZTAGFCBNDBBFZ-UHFFFAOYSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 235000019303 thiodipropionic acid Nutrition 0.000 description 1
- 229940094937 thioredoxin Drugs 0.000 description 1
- 108060008226 thioredoxin Proteins 0.000 description 1
- 239000013008 thixotropic agent Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- GKASDNZWUGIAMG-UHFFFAOYSA-N triethyl orthoformate Chemical compound CCOC(OCC)OCC GKASDNZWUGIAMG-UHFFFAOYSA-N 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229940040064 ubiquinol Drugs 0.000 description 1
- QNTNKSLOFHEFPK-UPTCCGCDSA-N ubiquinol-10 Chemical compound COC1=C(O)C(C)=C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(O)=C1OC QNTNKSLOFHEFPK-UPTCCGCDSA-N 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
- A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/06—Preparation of indole from coal-tar
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
- C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Kosmetische Zubereitungen, die Acrylnitril-Derivate enthalten, schützen die menschliche Haut und die Haare vor der UV-Strahlung.Cosmetic preparations that contain acrylonitrile derivatives protect human skin and hair from UV radiation.
Description
Die Erfindung betrifft kosmetische Zubereitungen zum Schutz der menschlichen Haut und menschlichen Haare vor den schädigenden Wirkungen der ultravioletten Sonnenstrahlung, die in diesen Zubereitungen enthaltenen neuen Acrylnitril-Derivate und ihre Verwendung als UV-Absorber. The invention relates to cosmetic preparations for protecting human Skin and human hair from the damaging effects of ultraviolet Solar radiation, the new acrylonitrile derivatives contained in these preparations and their use as UV absorbers.
UV-Absorber sind Verbindungen mit einem ausgeprägten Absorptionsvermögen für die Ultraviolettstrahlung. Sie werden insbesondere als Sonnenschutzmittel in kosmetischen und pharmazeutischen Präparaten, aber auch zur Verbesserung der Lichtbeständigkeit von technischen Produkten, wie Anstrichen, Lacken, Kunststoffen, Textilien, Polymeren wie z. B. Polymere und Copolymere von Mono- und Diolefinen, Polystyrole, Polyurethane, Polyamide, Polyester, Polyharnstoffe und Polycarbonate, Verpackungsmaterialien und Kautschuken verwendet. UV absorbers are compounds with a pronounced absorption capacity for the ultraviolet radiation. They are used in particular as a sunscreen cosmetic and pharmaceutical preparations, but also to improve Lightfastness of technical products such as paints, varnishes, plastics, Textiles, polymers such as B. polymers and copolymers of mono- and diolefins, Polystyrenes, polyurethanes, polyamides, polyesters, polyureas and polycarbonates, Packaging materials and rubbers used.
UV-Strahlen werden je nach Wellenlänge in UV-A-Strahlen (320-400 nm, UV-A-I: 340-400 nm, UV-A-II: 320-340 nm) oder UV-B-Strahlen (280-320 nm) eingeteilt. Depending on the wavelength, UV rays are converted into UV-A rays (320-400 nm, UV-A-I: 340-400 nm, UV-A-II: 320-340 nm) or UV-B rays (280-320 nm).
UV-Strahlen können akute und chronische Hautschädigungen bewirken, wobei die Art der Schädigung von der Wellenlänge der Strahlung abhängt. So kann die UV-B- Strahlung einen Sonnenbrand (Erythem) bis hin zu schwersten Hautverbrennungen verursachen. Auch Minderungen von Enzymaktivitäten, Schwächung des Immunsystems, Störungen der DNS-Struktur und Veränderungen an der Zellmembran als schädigende Wirkung der UV-B-Strahlen sind bekannt. Die UV-A-Strahlen dringen in tiefere Hautschichten ein und können dort den Alterungsprozeß der Haut beschleunigen. Die kürzerwellige UV-A-II-Strahlung verstärkt zusätzlich die Bildung von Sonnenbrand. Außerdem kann die UV-A-Strahlung phototoxische oder photoallergische Hautreaktionen auslösen. UV rays can cause acute and chronic skin damage, the Type of damage depends on the wavelength of the radiation. So the UV-B Radiation a sunburn (erythema) up to severe skin burns cause. Reductions in enzyme activities, weakening of the Immune system, disorders of the DNA structure and changes to the cell membrane as damaging effects of UV-B rays are known. The UV-A rays penetrate into deeper layers of the skin and there the aging process of the skin accelerate. The shorter-wave UV-A-II radiation additionally increases the formation from sunburn. In addition, UV-A radiation can be phototoxic or trigger photo-allergic skin reactions.
Sehr häufige und ungeschützte Bestrahlung der Haut mit Sonnenlicht führt zu einem Verlust der Hautelastizität und zu vermehrter Faltenbildung. In extremen Fällen werden krankhafte Hautveränderungen bis hin zum Hautkrebs beobachtet. Very frequent and unprotected exposure of the skin to sunlight leads to a Loss of skin elasticity and increased wrinkling. In extreme cases pathological skin changes up to skin cancer are observed.
Entsprechend der Lage ihrer Absorptionsmaxima werden UV-Absorber in UV-A- und UV-B-Absorber eingeteilt; wird von einem UV-Absorber sowohl UV-A als auch UV-B absorbiert, spricht man in diesem Fall von einen UV-A/B-Breitbandabsorber. Depending on the location of their absorption maxima, UV absorbers are converted into UV-A and UV-B absorber classified; is both UV-A and UV absorber UV-B absorbed, in this case one speaks of a UV-A / B broadband absorber.
Die Anzahl geeigneter UV-A-Absorber ist sehr begrenzt, und sie weisen erhebliche
Mängel auf:
So ist der insbesondere für den Schutz vor der UV-AI-Strahlung häufig eingesetzte
Filter 4-tert.-Butyl-4'-methoxy-dibenzoylmethan (Absorptionsmaximum bei 357 nm)
nicht photostabil. In Kombination mit den UV-B-Filtern p-Methoxyzimtsäure-2-
ethylhexyl- bzw. isoamylester beobachtet man auch Photoreaktionen. Außerdem hat
er nur eine begrenzte Löslichkeit in kosmetischen Ölen, was zu Problemen in der
Formulierung kosmetischer Zubereitungen führen kann. Ferner können
Dibenzoylmethanderivat-haltige Sonnenschutzprodukte auf Textilien extrem schwer
auswaschbare Flecken hinterlassen.
The number of suitable UV-A absorbers is very limited and they have significant shortcomings:
The filter 4-tert-butyl-4'-methoxy-dibenzoylmethane (absorption maximum at 357 nm), which is frequently used in particular for protection against UV-AI radiation, is not photostable. In combination with the UV-B filters p-methoxycinnamic acid 2-ethylhexyl or isoamyl ester, photoreactions are also observed. In addition, it has only a limited solubility in cosmetic oils, which can lead to problems in the formulation of cosmetic preparations. Furthermore, sun protection products containing dibenzoylmethane derivative can leave stains that are extremely difficult to wash out on textiles.
Es besteht daher für den UV-A-Bereich ein weiterer Bedarf an Lichtschutzmitteln für
die Verwendung in kosmetischen und pharmazeutischen Zubereitungen. Gesucht
werden lichtstabile UV-A-Absorber mit einer starken Absorption, so dass sie
wirksam vor den Schäden durch UV-Strahlen schützen. Weiterhin wird angestrebt,
dass für die Verwendung in kosmetischen Sonnenschutzmitteln diese UV-Absorber
daneben auch noch folgende Kriterien erfüllen:
- - Kompatibilität mit anderen UV-Absorbern unter Lichteinwirkung
- - bei kristallinen UV-Absorbern gute Löslichkeit in kosmetischen Lösungsmitteln und flüssigen, öllöslichen UV-Aborbern, wie z. B. p-Methoxyzimtsäure-ethyl-, -isoamyl- und -isooctylester, Ethylhexylsalicylat; Homomenthylsalicylat, Menthylanthranilat, p-Aminobenzoesäureethylhexylester, 3,3-Diphenyl-2-cyanoacrylsäure-ethyl- und -ethylhexylester;
- - flüssige, öllösliche UV-Absorber sollten mit anderen UV-Absorbern bzw. kosmetischen Ölkomponenten gut mischbar sein;
- - wasserresistenter UV-Schutz;
- - problemlose Verarbeitbarkeit in kosmetischen Formulierungen und Stabilität unter Anwendungsbedingungen;
- - Verträglichkeit mit kosmetischen Grundstoffen;
- - pH-Stabilität;
- - Thermostabilität;
- - keine oder problemlos auswaschbare Verfärbung von Textilien;
- - Farblosigkeit und Geruchsneutralität;
- - leicht bioabbaubar;
- - nicht wassergefährdend;
- - geringe Hautpenetration;
- - Brechungsindex > 1,5, um eine verbesserte Transparenz von Emulsionen zu erreichen.
- - Compatibility with other UV absorbers under the influence of light
- - With crystalline UV absorbers good solubility in cosmetic solvents and liquid, oil-soluble UV absorbers, such as. B. ethyl p-methoxycinnamic acid, isoamyl and isooctyl ester, ethylhexyl salicylate; Homomenthyl salicylate, menthyl anthranilate, ethylhexyl p-aminobenzoate, ethyl and ethylhexyl 3,3-diphenyl-2-cyanoacrylate;
- - Liquid, oil-soluble UV absorbers should be readily miscible with other UV absorbers or cosmetic oil components;
- - water resistant UV protection;
- - easy processing in cosmetic formulations and stability under conditions of use;
- - compatibility with cosmetic raw materials;
- - pH stability;
- - thermal stability;
- - no or easily washable discoloration of textiles;
- - colorless and odorless;
- - easily biodegradable;
- - not hazardous to water;
- - low skin penetration;
- - Refractive index> 1.5 in order to achieve improved transparency of emulsions.
Die Erfindung betrifft Lichtschutzzubereitungen enthaltend Acrylnitril-Derivate der
Formel (I), in der die C=C Doppelbindung in der E oder Z Konfiguration vorliegt,
worin
R1 Wasserstoff, C1-C20-Alkyl, C2-C20-Alkenyl, C2-C20-Alkinyl, C6-C12-
Aryl bedeuten kann,
R2 COOR13, COR13, CONR13R14, CN,
wobei R13-R14 für Wasserstoff, C1-C20-Alkyl, C2-C20-Alkenyl oder
C2-C20-Alkinyl, C6-C12-Aryl, C3-C15-Cycloalkyl, C5-C12-Heteroaryl
steht, die gegebenenfalls durch Amino, Hydroxy, Acetoxy, Carboxy,
Carbalkoxy, Carbamoyl, eine Gruppe W substituiert oder durch Ether-
Sauerstoff unterbrochen sein können,
R3-R12 die unter R1 angegebene Bedeutung haben oder auch C3-C15-
Cycloalkyl, C5-C12-Heteroaryl, C1-C16-Alkoxy, C6-C19-Aryloxy,
Amino, Hydroxy, Acetoxy, Carboxy, Carbalkoxy, Carbamoyl
bedeuten, wobei sie mit einer Gruppe W substituiert oder durch Ether-
Sauerstoff unterbrochen sein können,
mit der Maßgabe, dass auch zwei Substituenten von R3-R12 an
benachbarten C-Atomen zusammen eine gegebenenfalls substituierte
C1-C4-Alkylengruppe bedeuten können, wobei eine Methylengruppe
durch -O-, -S- oder NH- ersetzt sein kann,
z 0, 1 oder 2
W Silane, Oligosilane und Polysiloxane der allgemeinen Formeln WI bis WIII
WI SiR15 a(OSiR15 3)b
a 0, 1, 2 oder 3
b 3, 2, 1 oder 0
a + b 3
A eine Bindung zum Nachbaratom
c 1-10
R15 ein offenkettiger oder verzweigter aliphatischer, araliphatischer,
cycloaliphatischer oder gegebenenfalls substituierter aromatischer Rest mit jeweils
bis zu 18 C-Atomen
bedeuten.
The invention relates to light protection preparations containing acrylonitrile derivatives of the formula (I) in which the C = C double bond is in the E or Z configuration,
wherein
R 1 can denote hydrogen, C 1 -C 20 alkyl, C 2 -C 20 alkenyl, C 2 -C 20 alkynyl, C 6 -C 12 aryl,
R 2 COOR 13 , COR 13 , CONR 13 R 14 , CN, where R 13 -R 14 is hydrogen, C 1 -C 20 alkyl, C 2 -C 20 alkenyl or C 2 -C 20 alkynyl, C 6 -C 12 aryl, C 3 -C 15 cycloalkyl, C 5 -C 12 heteroaryl, which may optionally be substituted by amino, hydroxy, acetoxy, carboxy, carbalkoxy, carbamoyl, a group W or interrupted by ether oxygen .
R 3 -R 12 have the meaning given under R 1 or also C 3 -C 15 cycloalkyl, C 5 -C 12 heteroaryl, C 1 -C 16 alkoxy, C 6 -C 19 aryloxy, amino, hydroxy, Mean acetoxy, carboxy, carbalkoxy, carbamoyl, where they can be substituted by a group W or interrupted by ether oxygen,
with the proviso that two substituents of R 3 -R 12 on adjacent C atoms together can mean an optionally substituted C 1 -C 4 alkylene group, it being possible for a methylene group to be replaced by -O-, -S- or NH- .
z 0, 1 or 2
W silanes, oligosilanes and polysiloxanes of the general formulas W I to W III
W I SiR 15 a (OSiR 15 3 ) b
a 0, 1, 2 or 3
b 3, 2, 1 or 0
a + b 3
A is a bond to the neighboring atom
c 1-10
R 15 is an open-chain or branched aliphatic, araliphatic, cycloaliphatic or optionally substituted aromatic radical, each having up to 18 carbon atoms
mean.
Als Alkylreste seien beispielsweise Methyl, Ethyl, n-Propyl, 1-Methylethyl, n-Butyl, 1-Methylpropyl-, 2-Methylpropyl, 1,1-Dimethylethyl, n-Pentyl, 1-Methylbutyl, 2-Methylbutyl, 3-Methylbutyl, 2,2-Dimethylpropyl, 1-Ethylpropyl, n-Hexyl, 1,1-Dimethylpropyl, 1,2-Dimethylpropyl, 1-Methylpentyl, 2-Methylpentyl, 3-Methylpentyl, 4-Methylpentyl, 1,1-Dimethylbutyl, 1,2-Dimethylbutyl, 1,3-Dimethylbutyl, 2,2- Dimethylbutyl, 2,3-Dimethylbutyl, 3,3-Dimethylbutyl, 1-Ethylbutyl, 2-Ethylbutyl, 1,1,2-Trimethylpropyl, 1,2,2-Trimethylpropyl, 1-Ethyl-1-methylpropyl, 1-Ethyl-2- methylpropyl, n-Heptyl, n-Octyl, 2-Ethylhexyl, n-Nonyl, n-Decyl, n-Undecyl und n- Dodecyl genannt. Examples of alkyl radicals are methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl-, 2-methylpropyl, 1,1-dimethylethyl, n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, n-hexyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2- Dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethyl-1-methylpropyl, 1-ethyl-2- methylpropyl, n-heptyl, n-octyl, 2-ethylhexyl, n-nonyl, n-decyl, n-undecyl and n- Called dodecyl.
Als Alkoxyreste sind beispielsweise Methoxy-, Ethoxy-, iso-Propoxy-, n-Propoxy-, 1-Methylpropoxy-, n-Butoxy-, n-Pentoxy-, 2-Methylpropoxy-, 3-Methylbutoxy-, 1,1-Dimethylpropoxy-, 2,2-Dimethylpropoxy-, Hexoxy-, Heptoxy-, Octoxy- zu nennen. Examples of alkoxy radicals are methoxy, ethoxy, iso-propoxy, n-propoxy, 1-methylpropoxy, n-butoxy, n-pentoxy, 2-methylpropoxy, 3-methylbutoxy, 1,1-dimethylpropoxy, 2,2-dimethylpropoxy, hexoxy, heptoxy, octoxy call.
Bevorzugt sind Verbindungen der Formel (IA)
worin
R1 Wasserstoff, C1-C12-Alkyl, C2-C12-Alkenyl, C2-C12-Alkinyl, Phenyl
bedeuten kann,
R2 COOR13, COR13,
wobei R13 für Wasserstoff, C1-C12-Alkyl, C2-C12-Alkenyl, C2-C12-
Alkinyl oder C6-C12-Aryl steht, die gegebenenfalls durch Amino,
Hydroxy, Acetoxy, Carboxy, Carbalkoxy, Carbamoyl, eine Gruppe W
substituiert oder durch Ether-Sauerstoff unterbrochen sein können,
R3-R12 die unter R1 angegebene Bedeutung haben oder auch C3-C15-
Cycloalkyl, C5-C12-Heteroaryl, C1-C16-Alkoxy, C6-C12-Aryloxy,
Amino, Hydroxy, Acetoxy, Carboxy, Carbalkoxy, Carbamoyl
bedeuten, wobei sie mit einer Gruppe W substituiert oder durch Ether-
Sauerstoff unterbrochen sein können,
mit der Maßgabe, dass auch zwei Substituenten von R3-R12 an
benachbarten C-Atomen zusammen eine gegebenenfalls substituierte
C1-C4-Alkylengruppe bedeuten können, und
z 0, 1 oder 2 bedeutet.
Compounds of the formula (IA) are preferred
wherein
R 1 can be hydrogen, C 1 -C 12 alkyl, C 2 -C 12 alkenyl, C 2 -C 12 alkynyl, phenyl,
R 2 COOR 13 , COR 13 ,
where R 13 represents hydrogen, C 1 -C 12 alkyl, C 2 -C 12 alkenyl, C 2 -C 12 alkynyl or C 6 -C 12 aryl, which may be replaced by amino, hydroxy, acetoxy, carboxy, Carbalkoxy, carbamoyl, a group W substituted or interrupted by ether oxygen,
R 3 -R 12 have the meaning given under R 1 or also C 3 -C 15 cycloalkyl, C 5 -C 12 heteroaryl, C 1 -C 16 alkoxy, C 6 -C 12 aryloxy, amino, hydroxy, Mean acetoxy, carboxy, carbalkoxy, carbamoyl, where they can be substituted by a group W or interrupted by ether oxygen,
with the proviso that two substituents of R 3 -R 12 on adjacent C atoms together can mean an optionally substituted C 1 -C 4 alkylene group, and
z means 0, 1 or 2.
Besonders bevorzugt sind Verbindungen der Formel (IB)
worin
R1 Wasserstoff, C1-C6-Alkyl, Phenyl bedeuten kann,
R3-R12 Wasserstoff, C12-Alkyl, C2-C12-Alkenyl, C2-C12-Alkinyl, Phenyl,
C1-C12-Alkoxy, Hydroxy, Acetoxy, Carboxy, Carbalkoxy, Carbamoyl
bedeuten können, wobei sie mit einer Gruppe W substituiert oder
durch Ether-Sauerstoff unterbrochen sein können,
mit der Maßgabe, dass auch zwei Substituenten von R3-R8 an
benachbarten C-Atomen zusammen eine gegebenenfalls substituierte
C1-C4-Alkylengruppe bedeuten können,
R16-R18 unabhängig voneinander Wasserstoff, C1-C12-Alkyl, C2-C12-Alkenyl,
C2-C12-Alkinyl, bedeuten können, wobei diese mit C1-C12-Alkoxy,
Hydroxy, Acetoxy, Carboxy, Carbalkoxy, Carbamoyl, einer Gruppe W
substituiert oder durch Ether-Sauerstoff unterbrochen sein können,
z 0, 1 oder 2
bedeutet.
Compounds of the formula (IB) are particularly preferred
wherein
R 1 can denote hydrogen, C 1 -C 6 alkyl, phenyl,
R 3 -R 12 can denote hydrogen, C 12 alkyl, C 2 -C 12 alkenyl, C 2 -C 12 alkynyl, phenyl, C 1 -C 12 alkoxy, hydroxy, acetoxy, carboxy, carbalkoxy, carbamoyl, where they can be substituted by a group W or interrupted by ether oxygen,
with the proviso that two substituents of R 3 -R 8 on adjacent C atoms together can mean an optionally substituted C 1 -C 4 alkylene group,
R 16 -R 18 independently of one another can be hydrogen, C 1 -C 12 alkyl, C 2 -C 12 alkenyl, C 2 -C 12 alkynyl, these with C 1 -C 12 alkoxy, hydroxy, acetoxy , Carboxy, carbalkoxy, carbamoyl, a group W substituted or interrupted by ether oxygen,
z 0, 1 or 2
means.
Ganz besonders bevorzugt sind 3-Oxo-4,4-dimethyl-pentannitrile (Verbindungen der Formel (IB) mit R16-R18 = CH3). 3-Oxo-4,4-dimethyl-pentanenitrile (compounds of the formula (IB) with R 16 -R 18 = CH 3 ) are very particularly preferred.
Im Einzelnen seien die folgenden ganz besonders bevorzugten 3-Oxo-4,4-dimethyl-
pentannitrile genannt:
2-[(2,3-Dihydro-1H-indol-1-yl)methylen]-4,4-dimethyl-3-oxo-pentannitril, 2-[(2,3-
Dihydro-2-methyl-1H-indol-1-yl)methylen]-4,4-dimethyl-3-oxo-pentannitril, 2-[(2,3-
Dihydro-5-methyl-1H-indol-1-yl)methylen]-4,4-dimethyl-3-oxo-pentannitril,
2-[(2,3-Dihydro-2,3-dimethyl-1H-indol-1-yl)methylen]-4,4-dimethyl-3-oxo-pentannitril, 2-[(2,3-Dihydro-2,5-dimethyl-1H-indol-1-yl)methylen]-4,4-dimethyl-3-oxo-
pentannitril,
2-[(2,3-Dihydro-2,3,3-trimethyl-1H-indol-1-yl)methylen]-4,4-dimethyl-3-oxo-
pentannitril,
2-[(2,3-Dihydro-5-methoxy-1H-indol-1-yl)methylen]-4,4-dimethyl-3-oxo-
pentannitril, 2-[(2,3-Dihydro-2-methyl-5-methoxy-1H-indol-1-yl)methylen]-4,4-
dimethyl-3-oxo-pentannitril, 2-[(2,3-Dihydro-2,3,3-trimethyl-5-methoxy-1H-indol-1-
yl)methylen]-4,4-dimethyl-3-oxo-pentannitril,
2-[1-(2,3-Dihydro-2-methyl-1H-indol-1-yl)ethyliden]-4,4-dimethyl-3-oxo-
pentannitril,
2-[1-(3,4-Dihydro-1(2H)-quinolinyl)ethyliden]-4,4-dimethyl-3-oxo-pentannitril und
2-[(1,2,3,4,10,11-Hexahydro-9H-carbazol-9-yl)methylen]-4,4-dimethyl-3-oxo-
pentannitril.
The following are particularly preferred 3-oxo-4,4-dimethyl-pentanenitriles:
2 - [(2,3-dihydro-1H-indol-1-yl) methylene] -4,4-dimethyl-3-oxopentanenitrile, 2 - [(2,3-dihydro-2-methyl-1H-indole -1-yl) methylene] -4,4-dimethyl-3-oxopentanenitrile, 2 - [(2,3-dihydro-5-methyl-1H-indol-1-yl) methylene] -4,4-dimethyl -3-oxopentanenitrile, 2 - [(2,3-dihydro-2,3-dimethyl-1H-indol-1-yl) methylene] -4,4-dimethyl-3-oxopentanenitrile, 2 - [( 2,3-dihydro-2,5-dimethyl-1H-indol-1-yl) methylene] -4,4-dimethyl-3-oxopentanenitrile,
2 - [(2,3-dihydro-2,3,3-trimethyl-1H-indol-1-yl) methylene] -4,4-dimethyl-3-oxopentanenitrile,
2 - [(2,3-Dihydro-5-methoxy-1H-indol-1-yl) methylene] -4,4-dimethyl-3-oxopentanenitrile, 2 - [(2,3-dihydro-2-methyl -5-methoxy-1H-indol-1-yl) methylene] -4,4-dimethyl-3-oxopentanenitrile, 2 - [(2,3-dihydro-2,3,3-trimethyl-5-methoxy- 1H-indol-1-yl) methylene] -4,4-dimethyl-3-oxopentanenitrile,
2- [1- (2,3-dihydro-2-methyl-1H-indol-1-yl) ethylidene] -4,4-dimethyl-3-oxopentanenitrile,
2- [1- (3,4-dihydro-1 (2H) -quinolinyl) ethylidene] -4,4-dimethyl-3-oxopentanenitrile and
2 - [(1,2,3,4,10,11-Hexahydro-9H-carbazol-9-yl) methylene] -4,4-dimethyl-3-oxopentanenitrile.
Die Verbindungen der Formel (I) können nach an sich bekannten Verfahren hergestellt werden, zum Beispiel durch gemeinsames Erhitzen von NH-Heterocyclen mit Orthocarbonsäureestern und CH-aciden Verbindungen. Als NH-Heterocyclen können beispielsweise Indolin, 2-Methyl-indolin, 2,3,3-Trimethylindolin, 2,3,3- Trimethyl-5-methoxy-indolin, 5-Methoxy-indolin, 1,2,3,4,5,10,11-Hexahydrocarbazol und 1,2,3,4-Tetrahydrochinolin eingesetzt werden. Mögliche Orthocarbonsäureester sind beispielhaft Orthoameisensäuretrimethylester, Orthoameisensäuretriethylester, Orthoessigsäuretriethylester, Orthopropionsäuretriethylester, Orthobenzoesäuretrimethylester. Als CH-acide Verbindungen können zum Beispiel Cyanessigsäureethylester, Cyanessigsäure-3-methylbutylester, Cyanessigsäure-2- ethylhexylester, Malonsäuredinitril oder Pivaloylacetonitril eingesetzt werden. The compounds of the formula (I) can be prepared by processes known per se be prepared, for example by heating NH heterocycles together with orthocarboxylic acid esters and CH-acidic compounds. As NH heterocycles can, for example, indoline, 2-methyl-indoline, 2,3,3-trimethylindoline, 2,3,3- Trimethyl-5-methoxy-indoline, 5-methoxy-indoline, 1,2,3,4,5,10,11-hexahydrocarbazole and 1,2,3,4-tetrahydroquinoline can be used. Possible Orthocarboxylic acid esters are exemplified by trimethyl orthoformate, Triethyl orthoformate, triethyl orthoacetate, triethyl orthopropionate, Orthobenzoesäuretrimethylester. As CH-acidic compounds, for example Ethyl cyanoacetate, 3-methylbutyl cyanoacetate, 2- cyanoacetic acid ethylhexyl ester, malononitrile or pivaloylacetonitrile can be used.
Die höheren Alkylester der Formel (I) können auch aus den Methyl- oder Ethylestern durch Umesterung mit höheren Alkoholen gewonnen werden. The higher alkyl esters of the formula (I) can also be obtained from the methyl or ethyl esters can be obtained by transesterification with higher alcohols.
Die Verwendung von Acrylnitril-Derivaten der allgemeinen Formel (I) als UV-Filter zum Schutz von technischen Produkten wie z. B. von Kunststoffen ist aus DE-A 15 68 541 bekannt. Kosmetische und pharmazeutische Lichtschutzzubereitungen unter Verwendung von Acrylnitril-Derivaten der Formel (I) als UV-A-Filter sind dagegen bisher nicht beschrieben. The use of acrylonitrile derivatives of the general formula (I) as UV filters to protect technical products such as B. of plastics is from DE-A 15 68 541 known. Cosmetic and pharmaceutical sunscreen preparations using acrylonitrile derivatives of the formula (I) as UV-A filters however, not previously described.
Die in der WO 97/14680 beanspruchten sulfonierten Acrylnitrile sind nicht für alle Anwendungen geeignet. Durch die extreme Wasserlöslichkeit dieser Verbindungen ist es zum Beispiel schwierig, mit diesen Verbindungen wasserfeste kosmetische Zubereitungen zu erzielen. The sulfonated acrylonitriles claimed in WO 97/14680 are not for everyone Suitable for applications. Due to the extreme water solubility of these compounds For example, it is difficult to make waterproof cosmetic with these compounds To achieve preparations.
Die öllöslichen Acrylnitril-Derivate der Formel (I) zeichnen sich durch eine starke Absorption im UV-A-Bereich aus und weisen außerdem eine ausgezeichnete Lichtbeständigkeit auf. The oil-soluble acrylonitrile derivatives of the formula (I) are notable for being strong Absorption in the UV-A range and also have an excellent Lightfastness.
Sie sind photostabil und verfügen über eine gute Löslichkeit in kosmetischen Lösungsmitteln und in flüssigen öllöslichen UV-Absorbern. Mit diesen Verbindungen können problemlos in jeglicher Hinsicht stabile kosmetische Zubereitungen hergestellt werden. They are photostable and have good solubility in cosmetics Solvents and in liquid oil-soluble UV absorbers. With these Compounds can easily be stable cosmetic in any way Preparations are made.
Insbesondere mit den ganz besonders bevorzugten 3-Oxo-4,4-dimethyl-pentannitrilen kann aufgrund ihrer starken Absorption im UV-A-I-Bereich ein guter Schutz vor der längerwelligen UV-A-Strahlung erreicht werden. In particular with the very particularly preferred 3-oxo-4,4-dimethyl-pentanenitriles due to its strong absorption in the UV-A-I range, it can provide good protection from the longer-wave UV-A radiation can be achieved.
Die Acrylnitril-Derivate der Formel (I) können daher als UV-Absorber in kosmetischen Mitteln, insbesondere zum Schutz vor akuten (Sonnenbrand) sowie chronischen (frühzeitiger Hautalterung) Hautschäden besonders in Sonnenschutzmitteln, Tagespflegeprodukten und Haarpflegeprodukten verwendet werden. The acrylonitrile derivatives of the formula (I) can therefore be used as UV absorbers in cosmetic products, in particular for protection against acute (sunburn) as well chronic (early skin aging) skin damage especially in Sunscreens, day care products and hair care products are used.
Die Acrylnitril-Derivate der Formel (I) führen in kosmetischen Zubereitungen auch zur Photostabilisierung von UV-Absorbern mit geringerer UV-Lichtstabilität (vgl. Tab. 2). The acrylonitrile derivatives of the formula (I) also result in cosmetic preparations for the photostabilization of UV absorbers with lower UV light stability (cf. Tab. 2).
Insbesondere bewirken sie eine Stabilisierung des sehr lichtinstabilen UV-A- Absorbers 4-tert.-Butyl-4'-methoxydibenzoylmethan. In particular, they stabilize the very light-unstable UV-A Absorber 4-tert-butyl-4'-methoxydibenzoylmethane.
Obwohl sich das Absorptionsmaximum der Acrylnitril-Derivate der Formel (I) im UV-A-I-Bereich befindet, wird mit diesen Acrylnitril-Derivaten überraschenderweise auch eine Verbesserung der Photostabilität z. B. der UV-B-Filter p-Methoxyzimtsäure-2-ethylhexyl- oder -isoamylester erreicht. Although the absorption maximum of the acrylonitrile derivatives of the formula (I) in UV-A-I range, is surprisingly with these acrylonitrile derivatives also an improvement in photostability z. B. the UV-B filter p-Methoxycinnamic acid 2-ethylhexyl or isoamyl ester reached.
Ebenso wird eine Kombination der UV-Filter p-Methoxy-zimtsäure-2-ethylhexyl- bzw. -isoamylester mit 4-tert.-Butyl-4'-methoxy-dibenzoylmethan in kosmetischen Zubereitungen durch die Acrylnitril-Derivate der Formel (I) stabilisiert. A combination of the UV filters p-methoxy-cinnamic acid-2-ethylhexyl or isoamyl ester with 4-tert-butyl-4'-methoxy-dibenzoylmethane in cosmetic Preparations stabilized by the acrylonitrile derivatives of the formula (I).
Lichtschutzzubereitungen mit verbesserter Photostabilität werden erreicht durch Einsatz von 0,1-10 Gew.-%, bevorzugt 1-10 Gew.-%, p-Methoxyzimtsäure-2-ethylhexylester, p-Methoxyzimtsäureisoamylester oder 4-tert.-Butyl-4'-methoxy-dibenzoylmethan mit 0,1-10 Gew.-% einer Verbindung der Formel (I). Sunscreen preparations with improved photostability are achieved by Use of 0.1-10% by weight, preferably 1-10% by weight, p-methoxycinnamic acid 2-ethylhexyl ester, p-methoxycinnamic acid isoamyl ester or 4-tert-butyl-4'-methoxy-dibenzoylmethane with 0.1-10% by weight of a compound of formula (I).
Kosmetische Formulierungen mit erhöhter Lichtstabilität lassen sich auch herstellen durch Dreierkombination von Dibenzoylmethanderivaten und p-Methoxyzimzsäureestern mit Acrylnitril-Derivaten der Formel (I) durch Einsatz von z. B. 0,1-5 Gew.-% 4-tert.-Butyl-4'-methoxy-dibenzoylmethan, bevorzugt 1-3 Gew.-%, 0,1-10 Gew.-% p-Methoxyzimtsäure-2-ethylhexylester, bevorzugt 1,0-7,5 Gew.-%, und mindestens 0,2 Gew.-% einer Verbindung der Formel (I), bevorzugt 1,0-6,0 Gew.-%, bevorzugt im Verhältnis 1 Teil Dibenzoylmethanderivat, 2 Teile p-Methoxyzimtsäureester und 2 Teile der Verbindung der Formel (I). Cosmetic formulations with increased light stability can also be produced through a combination of three of dibenzoylmethane derivatives and p-Methoxyzimzäureestern with acrylonitrile derivatives of the formula (I) by using z. B. 0.1-5% by weight 4-tert-butyl-4'-methoxy-dibenzoylmethane, preferably 1-3% by weight, 0.1-10% by weight of 2-ethylhexyl p-methoxycinnamate, preferably 1.0-7.5% by weight, and at least 0.2% by weight of a compound of the formula (I), preferably 1.0-6.0% by weight, preferably in the ratio 1 part of dibenzoylmethane derivative, 2 parts p-methoxycinnamic acid ester and 2 parts of the compound of formula (I).
Vorteilhaft ist es weiterhin, zu dieser Dreierkombination einen oder mehrere sehr photostabile UV-Absorber, wie z. B. Methylbenzylidencampher, 2-Ethylhexyl-2- cyano-3,3'-diphenylacrylat, Octyltriazon, Uvasorb®HEB, Tinosorb®S, Tinosorb®M, Ethylhexylsalicylat, Homomenthylsalicylat sowie Phenylenbenzimidazolsulfonsäure oder Phenylen-bis-benzimidazol-tetrasulfonsäure-dinatriumsalz, Mexoryl®SX, Mexoryl®XL oder Parsol®SLX, hinzuzusetzen. It is also advantageous to add one or more to this combination of three photostable UV absorbers, such as B. methylbenzylidene camphor, 2-ethylhexyl-2- cyano-3,3'-diphenyl acrylate, octyltriazon, Uvasorb®HEB, Tinosorb®S, Tinosorb®M, Ethylhexyl salicylate, homomenthyl salicylate and phenylene benzimidazole sulfonic acid or phenylene-bis-benzimidazole-tetrasulfonic acid disodium salt, Mexoryl®SX, Mexoryl®XL or Parsol®SLX.
Weiterhin wird in kosmetischen Zubereitungen überraschenderweise durch die Verwendung von Acrylnitril-Derivaten der Formel (I) in Kombination mit anderen UV-Filtern eine synergistische Erhöhung des Sonnenschutzfaktors erreicht. Beispiele für eine synergistische Erhöhung des Sonnenschutzfaktors sind kosmetische Emulsionen, die sowohl eine Verbindung der Formel (I) als auch Etylhexylmethoxycinnamat oder Octocrylene, oder eine Kombination von Verbindung der Formel (I) mit Ethylhexylmethoxycinnamat und 2-Phenylbenzimidazolsulfonsäure, oder Ethylhexyl-methoxycinnamat und Methylbenzylidencampher, oder Ethylhexylmethoxycinnamat und 4-t-Butyl-4'-methoxy-dibenzoylmethan, oder Neo Heliopan® AP und Ethyl-hexylmethoxycinnamat, oder eine Kombination von Verbindung der Formel (I) mit Octocrylene, Methylbenzylidencampher und Zinkoxid enthält. Ebenfalls weisen Kombinationen von Verbindung der Formel (I) mit Dibenzoylmethanen, Methylbenzylidencampher, 2-Phenylbenzimidazolsulfonsäure, Neo Heliopan®AP, Mexoryl®SX, Mexoryl®XL, Parsol®SLX, Tinosorb®S, Tinosorb®M, Uvinul®T150, Uvasorb®HEB sowie mikrofeinen Pigmenten, Zinkoxid und Titandioxid, synergistische Erhöhungen des Sonnenschutzfaktors auf. Die genannten UV-Filter- Kombinationen sind beispielhaft angeführt und nicht auf die oben genannten Kombinationen beschränkt zu verstehen. So können alle oben bereits genannten besonders geeigneten UV-Absorber sowie alle in den Monographien oder Positivlisten (USA, Europa, Japan, Australien, Südafrika und anderen Ländern) zugelassenen UV-Filter mit Verbindungen der Formel (I) oder o. a. Kombinationen, einzeln oder in beliebigen Mischungen, kombiniert eingesetzt werden. Üblicherweise wird durch diese Kombinationen eine synergistische Erhöhung des UV-Sonnenschutzfaktors erzielt. Furthermore, in cosmetic preparations, surprisingly, by Use of acrylonitrile derivatives of the formula (I) in combination with others UV filters achieved a synergistic increase in the sun protection factor. Examples for a synergistic increase in the sun protection factor are cosmetic Emulsions containing both a compound of formula (I) and Ethylhexyl methoxycinnamate or octocrylene, or a combination of compound of formula (I) with ethylhexyl methoxycinnamate and 2-phenylbenzimidazole sulfonic acid, or Ethylhexyl methoxycinnamate and methylbenzylidene camphor, or Ethylhexyl methoxycinnamate and 4-t-butyl-4'-methoxy-dibenzoylmethane, or Neo Heliopan® AP and ethyl hexyl methoxycinnamate, or a combination of the compound Formula (I) with octocrylene, methylbenzylidene camphor and zinc oxide contains. Combinations of compound of the formula (I) with dibenzoylmethanes also have Methylbenzylidene camphor, 2-phenylbenzimidazole sulfonic acid, Neo Heliopan®AP, Mexoryl®SX, Mexoryl®XL, Parsol®SLX, Tinosorb®S, Tinosorb®M, Uvinul®T150, Uvasorb®HEB and microfine pigments, zinc oxide and titanium dioxide, synergistic increases in the sun protection factor. The UV filter mentioned Combinations are given as examples and not on the above Combinations to understand limited. So can all of the above particularly suitable UV absorber as well as all in the monographs or Positive lists (USA, Europe, Japan, Australia, South Africa and other countries) approved UV filter with compounds of formula (I) or the like combinations individually or in any mixtures, combined. Usually is a synergistic increase of the UV sun protection factor achieved.
Die Kombination von Verbindungen der Formel (I) mit UV-A-Absorbern, besonders UV-A-II-Absorbern, ergibt einen umfassenden Schutz gegen die UV-A-Strahlung (320-400 nm). Insbesondere eine Kombination von Verbindungen der Formel (I) mit Neo Heliopan®AP (UV-AII-Absorber) ist für eine breite UV-A-Schutzleistung zu nennen. Weitere UV-A-Filter, die in Kombination mit Verbindungen der Formel (I) allein oder in Kombination von Verbindungen der Formel (I) und Neo Heliopan®AP bevorzugt werden, sind Mexoryl SX, Mexoryl®XL, Tinosorb®M, Tinosorb®S, Benzophenon-3, Benzophenon-4, Neo Heliopan®357 und Neo Heliopan®MA. The combination of compounds of formula (I) with UV-A absorbers, especially UV-A-II absorbers provide comprehensive protection against UV-A radiation (320-400 nm). In particular a combination of compounds of formula (I) with Neo Heliopan®AP (UV-AII absorber) is for a broad UV-A protection performance too call. Further UV-A filters which, in combination with compounds of the formula (I) alone or in combination of compounds of formula (I) and Neo Heliopan®AP are preferred are Mexoryl SX, Mexoryl®XL, Tinosorb®M, Tinosorb®S, Benzophenone-3, Benzophenone-4, Neo Heliopan®357 and Neo Heliopan®MA.
Für eine optimale Breitbandschutzleistung gegen UV-A- und UV-B-Strahlung sind vorgenannte Kombinationen mit allen UV-B-Filtern und Mischungen aus diesen Filtern zu kombinieren (vgl. oben genannte besonders geeignete Uv-Absorber). Bevorzugt geeignet sind Neo Heliopan®AV, Neo Heliopan®E1000, Neo Heliopan®Hydro, Neo Heliopan®MBC, Neo Heliopan®303, Neo Heliopan®OS, Neo Heliopan®HMS, Uvinul®T150, Uvasorb®HEB und Dimethylaminobenzoesäureethylhexylester. For optimal broadband protection performance against UV-A and UV-B radiation aforementioned combinations with all UV-B filters and mixtures of these Combine filters (see above particularly suitable UV absorbers). Neo Heliopan®AV, Neo Heliopan®E1000, Neo are particularly suitable Heliopan®Hydro, Neo Heliopan®MBC, Neo Heliopan®303, Neo Heliopan®OS, Neo Heliopan®HMS, Uvinul®T150, Uvasorb®HEB and Dimethylaminobenzoesäureethylhexylester.
Durch Kombination von Verbindungen der Formel (I) mit Neo Heliopan®AP und einem UV-B-Filter, z. B. Etylhexylmethoxycinnamat oder UV-B-Filtergemischen sowie beschichteten oder unbeschichteten feindispersen Metalloxiden wie z. B. Zinkoxid, Titandioxid wird eine UV-Breitband-Schutzleistung mit einer kritischen Wellenlänge λcrit. ≍ 380 nm erzielt (vgl. hierzu Diffey in Int. J. Cosm. Science 16, 47 (1994)). By combining compounds of formula (I) with Neo Heliopan®AP and a UV-B filter, e.g. B. ethylhexyl methoxycinnamate or UV-B filter mixtures and coated or uncoated finely dispersed metal oxides such. B. zinc oxide, titanium dioxide is a UV broadband protection performance with a critical wavelength λ crit. ≍ 380 nm achieved (see also Diffey in Int. J. Cosm. Science 16, 47 (1994)).
Synergien der Acrylnitril-Derivate der Formel (I) mit anderen nicht UV-Licht absorbierenden Bestandteilen bezüglich eines verbesserten Schutzes gegenüber UV- Licht sind zu erwarten. Synergies of the acrylonitrile derivatives of the formula (I) with other non-UV light absorbent components for improved protection against UV Light is expected.
Sonnenschutzprodukte sollen wasserfest sein, damit ein ausreichender UV-Schutz für den Anwender, insbesondere Kinder, nach dem Schwimmen oder Baden gewährleistet ist. Die UV-Absorber der Formel (I) erfüllen diese Anforderungen aufgrund ihres hydrophoben Charakters in besonderem Maße und eignen sich daher insbesondere auch für die Formulierung wasserresistenter Sonnenschutzprodukte. Weiterhin kann die Wasserfestigkeit von Sonnenschutzprodukten mit wasserlöslichen, einfach oder mehrfach sulfonierten UV-Filtern wie z. B. Neo Heliopan®AP, Mexoryl®SX, Benzophenon-4, Neo Heliopan®Hydro und den oben bereits genannten besonders geeigneten öllöslichen UV-Absorbern durch Kombination mit Verbindungen der Formel (I) signifikant erhöht werden. Sun protection products should be waterproof so that they have sufficient UV protection for the user, especially children, after swimming or bathing is guaranteed. The UV absorbers of the formula (I) meet these requirements on the basis of of their hydrophobic character to a particular extent and are therefore suitable especially for the formulation of water-resistant sun protection products. Furthermore, the water resistance of sun protection products with water-soluble, single or multiple sulfonated UV filters such as B. Neo Heliopan®AP, Mexoryl®SX, Benzophenon-4, Neo Heliopan®Hydro and those already mentioned above particularly suitable oil-soluble UV absorbers by combination with Compounds of formula (I) can be significantly increased.
Flüssige Acrylnitril-Derivate der Formel (I) eignen sich auch als Lösungsmittel für feste UV-Filter, für die beispielhaft aber nicht limitierend folgende Verbindungen genannt werden: Campher-Derivate (z. B. Benzylidencampher und Methylbenzylidencampher), Triazin-Derivate (z. B. Octyltriazin, Dioctylbutamidtriazin, Bis(ethylhexyloxy, hydroxy)phenyl, methoxyphenyltriazin), Benzophenon-Derivate (z. B. Oxybenzon), Dibenzoylmethan-Derivate (z. B. Butylmethoxydibenzoylmethan). Die Lösungseigenschaften der Acrylnitril-Derivate nach Formel (I) können erhöht werden, wenn sie mit anderen flüssigen Bestandteilen kosmetischer Zubereitungen, einschließlich anderer flüssiger UV-Filter, kombiniert werden. Aufgeführt seien beispielhaft aber nicht einschränkend: Ethylhexyl-p-methoxycinnamat, Isoamyl-p- methoxycinnamat, Ethylhexylsalicylat, Octocrylen, Menthylanthtanilat, Fettalkoholester, Fettsäureester, Alkylbenzoate usw. Liquid acrylonitrile derivatives of the formula (I) are also suitable as solvents for Fixed UV filters, for the following but not limiting examples are mentioned: camphor derivatives (e.g. benzylidene camphor and Methylbenzylidene camphor), triazine derivatives (e.g. octyltriazine, dioctylbutamide triazine, Bis (ethylhexyloxy, hydroxy) phenyl, methoxyphenyltriazine), benzophenone derivatives (e.g. Oxybenzone), dibenzoylmethane derivatives (e.g. butylmethoxydibenzoylmethane). The Solution properties of the acrylonitrile derivatives according to formula (I) can be increased if they are mixed with other liquid components of cosmetic preparations, including other liquid UV filters. Are listed exemplary but not restrictive: ethylhexyl p-methoxycinnamate, isoamyl p- methoxycinnamate, ethylhexyl salicylate, octocrylene, menthylanthanolate, Fatty alcohol esters, fatty acid esters, alkyl benzoates, etc.
Kristalline Acrylnitrile der Formel (I) müssen in kosmetischen Zubereitungen
ausreichend gelöst werden, um das Problem der Rekristallisation nach längerer
Lagerungszeit zu vermeiden. Eine ausreichende Menge der üblicherweise in
kosmetischen Zubereitungen eingesetzten Ölkomponenten, flüssiger öllöslicher UV-
Absorber oder Alkoholen, z. B. Ethanol, Isopropanol oder 1-Butanol, ist zur
Vermeidung der Rekristallisation erforderlich. Besonders bevorzugt ist der Einsatz
folgender Ölkomponenten und/oder UV-Absorber zur Erzielung einer ausreichenden
Löslichkeit der Acrylnitril-Derivate:
Ethylhexylmethoxycinnamat, Isoamyl-methoxycinnamat, Octocrylen,
Ethylhexylsalicylat, Homosalat, Menthylanthranilat, Padimate O, Diisopropyladipat, C12-15-
Alkyl-benzoat (Witconol TN), Butylenglykol-dicaprylat/-dicaprat (Miglyol 8810),
Cocoglyceride (Myritol 331), Capryl/capr.-triglyceride (Miglyol 812),
Cetearyl-isononanat (Cetiol SN), PVP/Hexadecen-Copolymer (Unimer U151), Adipinsäure-
/Diethylenglykol/Isononansäure-Copolymer (Lexorez 100),
Propylenglykoldicaprylat/Dicaprat (Myritol PC), Hexyllaurat (Cetiol A), Dicaprylether (Cetiol OE),
Diethylhexyl-naphthalat (Hallbrite®TQ), Butyloctylsalicylat (Hallbrite®BHB),
Dibutyladipat (Cetiol B), Triethylcitrat (Hydagen CAT), Propylenglykol-dibenzoat
(Finsolv PG 22), Tributylcitrat, Dioctylmalat (Ceraphyl 45), Dipropylenglykol-
dibenzoat (Benzoflex 245), Acetyl-tributylcitrat (Citroflex A-4), Acetyl-triethylcitrat
(Citroflex A-2). Die Aufzählung der genannten Öle, die im Sinne der vorliegenden
Erfindung eingesetzt werden können, soll selbstverständlich nicht limitierend sein.
Crystalline acrylonitriles of the formula (I) must be sufficiently dissolved in cosmetic preparations in order to avoid the problem of recrystallization after a long storage period. A sufficient amount of the oil components usually used in cosmetic preparations, liquid oil-soluble UV absorbers or alcohols, e.g. B. ethanol, isopropanol or 1-butanol is necessary to avoid recrystallization. The use of the following oil components and / or UV absorbers is particularly preferred in order to achieve sufficient solubility of the acrylonitrile derivatives:
Ethylhexyl methoxycinnamate, isoamyl methoxycinnamate, octocrylene, ethylhexyl salicylate, homosalate, menthyl anthranilate, Padimate O, diisopropyl adipate, C 12-15 - alkyl benzoate (Witconol TN), butylene glycol dicaprylate, cocylglycerol (33) dicaprylate (33) dicaplylate (33) dicaprylate (33) dicaprylate (33) /capr.-triglyceride (Miglyol 812), cetearyl-isononanate (Cetiol SN), PVP / hexadecene copolymer (Unimer U151), adipic acid / diethylene glycol / isononanoic acid copolymer (Lexorez 100), propylene glycol dicaprylate / dicaprate (myritolur PC) (Cetiol A), dicapryl ether (Cetiol OE), diethylhexyl naphthalate (Hallbrite®TQ), butyloctylsalicylate (Hallbrite®BHB), dibutyl adipate (Cetiol B), triethyl citrate (Hydagen CAT), propylene glycol dibcenzoate (Finsolvutylate 22), finsolvutylate (Finsolvutylate) Dioctyl malate (Ceraphyl 45), dipropylene glycol dibenzoate (Benzoflex 245), acetyl tributyl citrate (Citroflex A-4), acetyl triethyl citrate (Citroflex A-2). The list of the oils mentioned, which can be used in the sense of the present invention, should of course not be limiting.
Sehr nachteilig ist, wenn UV-Absorber auf Kleidungsstücken nicht mehr auswaschbare Flecken hinterlassen. Insbesondere ist von dem UV-A-Absorber tert.-Butylmethoxydibenzoylmethan bekannt, dass er nicht mehr auswaschbare Flecken auf Textilien erzeugt. Diesen Nachteil haben die erfindungsgemäßen Acrylnitrile nicht, da eine Fleckenbildung auf Textilien sehr gut auswaschbar ist. It is very disadvantageous if UV absorbers are no longer on clothing leave washable stains. In particular is from the UV-A absorber tert-Butylmethoxydibenzoylmethan known that he stains no longer washable Textiles. The acrylonitriles according to the invention do not have this disadvantage, because staining on textiles is very easy to wash out.
Gegenstand der vorliegenden Erfindung sind auch neue Acrylnitril-Derivate entsprechend Formel (IB) sowie ihre Verwendung als UV-Absorber, insbesondere in kosmetischen Zubereitungen. The present invention also relates to new acrylonitrile derivatives according to formula (IB) and their use as UV absorbers, especially in cosmetic preparations.
Die folgenden neuen Acrylnitril-Derivate der Formel (IB) sind besonders bevorzugt:
2-[(2,3-Dihydro-1H-indol-1-yl)methylen]-4,4-dimethyl-3-oxo-pentannitril
2-[(2,3-Dihydro-2-methyl-1H-indol-1-yl)methylen]-4,4-dimethyl-3-oxo-pentannitril
2-[(2,3-Dihydro-5-methyl-1H-indol-1-yl)methylen]-4,4-dimethyl-3-oxo-pentannitril
2-[(2,3-Dihydro-2,3-dimethyl-1H-indol-1-yl)methylen]-4,4-dimethyl-3-oxo-
pentannitril
2-[(2,3-Dihydro-2,5-dimethyl-1H-indol-1-yl)methylen]-4,4-dimethyl-3-oxo-
pentannitril
2-[(2,3-Dihydro-2,3,3-trimethyl-1H-indol-1-yl)methylen]-4,4-dimethyl-3-oxo-
pentannitril
2-[(2,3-Dihydro-5-methoxy-1H-indol-1-yl)methylen]-4,4-dimethyl-3-oxo-
pentannitril
2-[(2,3-Dihydro-2-methyl-5-methoxy-1H-indol-1-yl)methylen]-4,4-dimethyl-3-oxo-
pentannitril
2-[(2,3-Dihydro-2,3,3-trimethyl-5-methoxy-1H-indol-1-yl)methylen]-4,4-dimethyl-3-
oxo-pentannitril
2-[1-(2,3-Dihydro-1H-indol-1-yl)ethyliden]-4,4-dimethyl-3-oxo-pentannitril
2-[1-(2,3-Dihydro-2-methyl-1H-indol-1-yl)ethyliden]-4,4-dimethyl-3-oxo-
pentannitril
2-[1-(3,4-Dihydro-1(2H)-quinolinyl)ethyliden]-4,4-dimethyl-3-oxo-pentannitril
2-[(1,2,3,4,10,11-Hexahydro-9H-carbazol-9-yl)methylen]-4,4-dimethyl-3-oxo-
pentannitril.
The following new acrylonitrile derivatives of the formula (IB) are particularly preferred:
2 - [(2,3-dihydro-1H-indol-1-yl) methylene] -4,4-dimethyl-3-oxo-pentanenitrile
2 - [(2,3-dihydro-2-methyl-1H-indol-1-yl) methylene] -4,4-dimethyl-3-oxo-pentanenitrile
2 - [(2,3-dihydro-5-methyl-1H-indol-1-yl) methylene] -4,4-dimethyl-3-oxo-pentanenitrile
2 - [(2,3-Dihydro-2,3-dimethyl-1H-indol-1-yl) methylene] -4,4-dimethyl-3-oxopentanenitrile
2 - [(2,3-Dihydro-2,5-dimethyl-1H-indol-1-yl) methylene] -4,4-dimethyl-3-oxopentanenitrile
2 - [(2,3-Dihydro-2,3,3-trimethyl-1H-indol-1-yl) methylene] -4,4-dimethyl-3-oxopentanenitrile
2 - [(2,3-Dihydro-5-methoxy-1H-indol-1-yl) methylene] -4,4-dimethyl-3-oxopentanenitrile
2 - [(2,3-Dihydro-2-methyl-5-methoxy-1H-indol-1-yl) methylene] -4,4-dimethyl-3-oxopentanenitrile
2 - [(2,3-Dihydro-2,3,3-trimethyl-5-methoxy-1H-indol-1-yl) methylene] -4,4-dimethyl-3-oxopentanenitrile
2- [1- (2,3-dihydro-1H-indol-1-yl) ethylidene] -4,4-dimethyl-3-oxo-pentanenitrile
2- [1- (2,3-Dihydro-2-methyl-1H-indol-1-yl) ethylidene] -4,4-dimethyl-3-oxopentanenitrile
2- [1- (3,4-dihydro-1 (2H) -quinolinyl) ethylidene] -4,4-dimethyl-3-oxo-pentanenitrile
2 - [(1,2,3,4,10,11-Hexahydro-9H-carbazol-9-yl) methylene] -4,4-dimethyl-3-oxopentanenitrile.
Die UV-Absorber der Formel (I) verhindern beim Einsatz in kosmetischen oder pharmazeutischen Zubereitungen den Durchtritt der UV-Strahlen durch den aufgetragenen Film der Zubereitung. The UV absorbers of the formula (I) prevent use in cosmetic or pharmaceutical preparations the passage of UV rays through the applied film of the preparation.
Kosmetische und dermatologische Formulierungen im Sinne dieser Erfindung enthalten einen oder mehrere übliche UV-A-, UV-B- und/oder Breitbandfilter als Einzelsubstanzen oder in beliebigen Gemischen untereinander, in der Lipidphase und/oder in der wäßrigen Phase. Sie sind in jeglicher Hinsicht befriedigende Produkte, welche sich erstaunlicherweise durch eine hohe UV-A-Schutzleistung bzw. einen hohen Lichtschutzfaktor auszeichnen. Cosmetic and dermatological formulations in the sense of this invention contain one or more conventional UV-A, UV-B and / or broadband filters as Individual substances or in any mixtures with each other, in the lipid phase and / or in the aqueous phase. They are satisfactory in every way Products that are surprisingly characterized by high UV-A protection performance or distinguish a high sun protection factor.
Dies ist im allgemeinen der Fall, wenn die Zubereitungen 0,5 bis 15, vorzugsweise 1 bis 10, insbesondere 2 bis 7, Gew.-% (bezogen auf das Gesamtgewicht der Zubereitung) einer Verbindung der Formel (I) enthalten. This is generally the case when the preparations are 0.5 to 15, preferably 1 to 10, in particular 2 to 7 wt .-% (based on the total weight of the Preparation) contain a compound of formula (I).
Die erfindungsgemäßen kosmetischen und/oder dermatologischen Formulierungen können wie üblich zusammengesetzt sein und dem kosmetischen und/oder dermatologischen Lichtschutz, ferner zur Behandlung, der Pflege und der Reinigung der Haut und/oder der Haare und als Schminkprodukt in der dekorativen Kosmetik dienen. The cosmetic and / or dermatological formulations according to the invention can be composed as usual and the cosmetic and / or dermatological light protection, also for the treatment, care and cleaning of the Skin and / or hair and as a make-up product in decorative cosmetics serve.
Diese zum Schutz von Haut und Haaren vor der UV-Strahlung dienenden kosmetischen und pharmazeutischen Zubereitungen können in den üblicherweise verwendeten Anwendungsformen vorliegen, d. h. als Öl-in-Wasser-, Wasser-in-Öl- oder gemischter Emulsion, als Milch, als Lotion oder Creme, Aerosol, Hydrodispersions- oder Ölgel (emulgatorfrei), Spray, Schaum, Lösung, Puder, Stiftpräparat oder als jegliche andere übliche kosmetische oder pharmazeutische Zubereitung. Für den Schutz der Haare vor UV-Strahlen werden bevorzugt Zubereitungen als Shampoo, Spülung, Kur, Gel, Lotion, Spray oder Creme verwendet. These protect the skin and hair from UV radiation Cosmetic and pharmaceutical preparations can usually be found in the application forms used, d. H. as oil-in-water, water-in-oil or mixed emulsion, as milk, as a lotion or cream, aerosol, hydrodispersion or oil gel (emulsifier free), spray, foam, solution, powder, stick preparation or as any other common cosmetic or pharmaceutical preparation. For the Protection of the hair from UV rays are preferred preparations as shampoo, Conditioner, cure, gel, lotion, spray or cream used.
Entsprechend können die erfindungsgemäßen Zubereitungen, je nach ihrem Aufbau, beispielsweise verwendet werden als Hautschutzcrème, Reinigungsmilch, Sonnenschutzlotion, Nährcreme, Tages- oder Nachtcreme usw. Es ist gegebenenfalls möglich und vorteilhaft, die erfindungsgemäßen Zubereitungen als Grundlage für pharmazeutische Formulierungen zu verwenden. Bevorzugt sind insbesondere solche kosmetischen und dermatologischen Zubereitungen, die in der Form eines Hautpflege- bzw. Schminkproduktes vorliegen. Accordingly, the preparations according to the invention, depending on their structure, used for example as skin protection cream, cleansing milk, Sunscreen lotion, nutrient cream, day or night cream, etc. It may be possible and advantageous, the preparations according to the invention as a basis for to use pharmaceutical formulations. Those are particularly preferred cosmetic and dermatological preparations in the form of a Skin care or make-up product available.
Zur Anwendung werden die erfindungsgemäßen kosmetischen und dermatologischen Zubereitungen in der für Kosmetika üblichen Weise auf die Haut und/oder die Haare in ausreichender Menge aufgebracht. Besonders bevorzugt sind solche kosmetischen und dermatologischen Zubereitungen, die in der Form eines Sonnenschutzmittels vorliegen. The cosmetic and dermatological agents according to the invention are used Preparations on skin and / or hair in the manner customary for cosmetics applied in sufficient quantity. Such cosmetic ones are particularly preferred and dermatological preparations in the form of a sunscreen available.
Die erfindungsgemäßen kosmetischen und dermatologischen Zubereitungen können
kosmetische Hilfsstoffe enthalten, wie sie üblicherweise in solchen Zubereitungen
verwendet werden. z. B.:
Emulgatoren, grenzflächenaktive Verbindungen, Lanolin, Vaseline, Wasser, Fette,
(z. B. Triglyceride von Fettsäuren), Polyethylenglykole, Fettalkohole, ethoxylierte
Fettalkohole, Fettsäureester (z. B. Isopropylpalmitat, Isooctylstearat,
Adipinsäurediisopropylester usw.), natürliche oder synthetische Öle oder Wachse, Pigmente,
(z. B. Titandioxid, Zinkoxid, Perglanzpigmente, Farbpigmente), Verdickungsmittel
(z. B. Hydroxyethylcellulose, Carboxymethylcellulose, Bentonit usw.),
Schaumstabilisatoren, Filmbildner, Farbstoffe, Elektolyte, pH-Regulatoren,
Konservierungsstoffe, Bakterizide, Feuchtigkeitsmittel, Vitamine und biogene Wirkstoffe
(z. B. Pflanzenextrakte und Eiweißhydrolysate), Siliconderivate, Alkohole und
Polyole, (z. B. Ethylalkohol, Isopropanol, Glycerin), Parfumöle, Polymere wie z. B.
Polyacrylate, Polyurethane, Polyglyceride, Polyvinyle, Alken- und Alkinpolymere,
Polysaccharide, Polyvinylpyrrolidon, Substanzen zum Verhindern des Schäumens,
Antioxidantien, Elektrolyte, organische Lösungsmittel, Komplexbildner,
Repellentien, Glyceride und Radikalfänger wie z. B. HALS (= "Hindered Amine Light
Stabilizers") oder Phenol-Derivate.
The cosmetic and dermatological preparations according to the invention can contain cosmetic auxiliaries, as are usually used in such preparations. z. B .:
Emulsifiers, surface-active compounds, lanolin, petroleum jelly, water, fats (e.g. triglycerides of fatty acids), polyethylene glycols, fatty alcohols, ethoxylated fatty alcohols, fatty acid esters (e.g. isopropyl palmitate, isooctyl stearate, diisopropyl adipate, etc.), natural or synthetic oils Waxes, pigments (e.g. titanium dioxide, zinc oxide, pearlescent pigments, color pigments), thickeners (e.g. hydroxyethyl cellulose, carboxymethyl cellulose, bentonite etc.), foam stabilizers, film formers, dyes, electrolytes, pH regulators, preservatives, bactericides, moisturizers , Vitamins and biogenic active substances (e.g. plant extracts and protein hydrolyzates), silicone derivatives, alcohols and polyols (e.g. ethyl alcohol, isopropanol, glycerin), perfume oils, polymers such as B. polyacrylates, polyurethanes, polyglycerides, polyvinyls, alkene and alkyne polymers, polysaccharides, polyvinylpyrrolidone, substances for preventing foaming, antioxidants, electrolytes, organic solvents, complexing agents, repellents, glycerides and radical scavengers such as. B. HALS (= "Hindered Amine Light Stabilizers") or phenol derivatives.
Als nicht ionische Emulgatoren bzw. Dispergatoren kommen in Frage die Gruppe, die gebildet wird von Polyglyceryl-2-dipolyhydroxystearate (Dehymuls®PGPH), Polyglyceryl-3-diiso-stearate (Lameform®TGI), Polyglyceryl-4-isostearate (Isolan®GI 34), Polyglyceryl-3-oleate, Diisostearyl-Polyglyceryl-3-diisostearate (Isolan®PDI), Polyglyceryl-3-methylglucose distearate (Tego Carey®450), Polyglyceryl-3-beeswax (Cera Bellina®), Polyglyceryl-4-caprate (Polyglycerol caprate T2010/90), Polyglyceryl-3-cetylether (Chimexane®NL), Polyglyceryl-3-distearate (Cremophor®GS 32), Polyglyceryl-2-stearate (Hostacerin®DGMS) und Polyglycerylpolyricineoleate (Admul®WOL 1403) sowie deren Gemischen. The following are suitable as nonionic emulsifiers or dispersants: which is formed from polyglyceryl-2-dipolyhydroxystearate (Dehymuls®PGPH), Polyglyceryl-3-diiso-stearate (Lameform®TGI), polyglyceryl-4-isostearate (Isolan®GI 34), polyglyceryl-3-oleates, diisostearyl-polyglyceryl-3-diisostearate (Isolan®PDI), Polyglyceryl-3-methylglucose distearate (Tego Carey®450), Polyglyceryl-3-beeswax (Cera Bellina®), Polyglyceryl-4-caprate (Polyglycerol caprate T2010 / 90), Polyglyceryl-3-cetylether (Chimexane®NL), Polyglyceryl-3-distearate (Cremophor®GS 32), polyglyceryl-2-stearate (Hostacerin®DGMS) and Polyglycerylpolyricineoleate (Admul®WOL 1403) and their mixtures.
Die Lipidphase der Zubereitungen kann vorteilhaft gewählt werden aus folgender
Substanzgruppe:
- - Mineralöle, Mineralwachse;
- - Öle, wie Triglyceride der Caprin- oder der Caprylsäure, ferner natürliche Öle wie z. B. Rizinusöl;
- - Fette, Wachse und andere natürliche und synthetische Fettkörper, vorzugsweise Ester von Fettsäuren mit Alkoholen niedriger C-Zahl, z. B. mit Isopropanol, Propylenglykol oder Glycerin, oder Ester von Fettalkoholen mit Alkansäuren niedriger C-Zahl oder mit Fettsäuren;
- - Alkylbenzoate;
- - Silikonöle wie Dimethylpolysiloxane, Diethylpolysiloxane, Diphenylpolysiloxane sowie Mischformen daraus.
- - mineral oils, mineral waxes;
- - Oils, such as triglycerides of capric or caprylic acid, as well as natural oils such. B. castor oil;
- - Fats, waxes and other natural and synthetic fat bodies, preferably esters of fatty acids with alcohols of low C number, e.g. B. with isopropanol, propylene glycol or glycerol, or esters of fatty alcohols with low C number alkanoic acids or with fatty acids;
- - alkyl benzoates;
- - Silicone oils such as dimethylpolysiloxanes, diethylpolysiloxanes, diphenylpolysiloxanes and mixed forms thereof.
Die Ölphase der Emulsionen, Oleogele bzw. Hydrodispersionen oder Lipodispersionen im Sinne der vorliegenden Erfindung wird vorteilhaft gewählt aus der Gruppe der Ester aus gesättigten und/oder ungesättigten, verzweigten und/oder unverzweigten Alkancarbonsäuren einer Kettenlänge von 3 bis 30 C-Atomen und gesättigten und/oder ungesättigten, verzweigten und/oder unverzweigten Alkoholen einer Kettenlänge von 3 bis 30 C-Atomen, aus der Gruppe der Ester aus aromatischen Carbonsäuren und gesättigten und/oder ungesättigten, verzweigten und/oder unverzweigten Alkoholen einer Kettenlänge von 3 bis 30 C-Atomen. Solche Esteröle können dann vorteilhaft gewählt werden aus der Gruppe Isopropylmyristat, Isopropylpalmitat, Isopropylstearat, Isopropyloleat, n-Butylstearat, n-Hexyllaurat, n- Decyloleat, Isooctylstearat, Isononylstearat, Isononylisononanoat, 2-Ethylhexylpalmitat, 2-Ethylhexyllaurat, 2-Hexyldecylstearat, 2-Octyldodecylpalmitat, Oleyloleat, Oleylerucat, Erucyloleat, Erucylerucat sowie synthetische, halb-synthetische und natürliche Gemische solcher Ester, z. B. Jojobaöl. The oil phase of the emulsions, oleogels or hydrodispersions or Lipodispersions in the sense of the present invention are advantageously selected from the group the ester of saturated and / or unsaturated, branched and / or unbranched alkane carboxylic acids with a chain length of 3 to 30 carbon atoms and saturated and / or unsaturated, branched and / or unbranched alcohols Chain length from 3 to 30 carbon atoms, from the group of aromatic esters Carboxylic acids and saturated and / or unsaturated, branched and / or unbranched alcohols with a chain length of 3 to 30 carbon atoms. Such ester oils can then advantageously be selected from the group of isopropyl myristate, Isopropyl palmitate, isopropyl stearate, isopropyl oleate, n-butyl stearate, n-hexyl laurate, n- Decyl oleate, isooctyl stearate, isononyl stearate, isononyl isononanoate, 2-ethylhexyl palmitate, 2-ethylhexyl laurate, 2-hexyldecyl stearate, 2-octyldodecyl palmitate, Oleyl oleate, Oleylerucat, Erucyloleat, Erucylerucat as well as synthetic, semi-synthetic and natural mixtures of such esters, e.g. B. Jojoba oil.
Ferner kann die Ölphase vorteilhaft gewählt werden aus der Gruppe der verzweigten und unverzweigten Kohlenwasserstoffe und -wachse, der Silkonöle, der Dialkylether, der Gruppe der gesättigten oder ungesättigten, verzweigten oder unverzweigten Alkohole, sowie der Fettsäuretriglyceride, namentlich der Triglycerinester gesättigter und/oder ungesättigter, verzweigter und/oder unverzweigter Alkancarbonsäuren einer Kettenlänge von 8 bis 24, insbesondere 12 bis 18 C-Atomen. Die Fettsäuretriglyceride können beispielsweise vorteilhaft gewählt werden aus der Gruppe der synthetischen, halbsynthetischen und natürlichen Öle, z. B. Olivenöl, Sonnenblumenöl, Sojaöl, Erdnußöl, Rapsöl, Mandelöl, Palmöl, Kokosöl, Palmkernöl und dergleichen mehr. Furthermore, the oil phase can advantageously be selected from the group of the branched ones and unbranched hydrocarbons and waxes, the silicone oils, the dialkyl ethers, the group of saturated or unsaturated, branched or unbranched Alcohols, as well as the fatty acid triglycerides, especially the triglycerol esters saturated and / or unsaturated, branched and / or unbranched alkane carboxylic acids Chain length of 8 to 24, especially 12 to 18 carbon atoms. The Fatty acid triglycerides can, for example, advantageously be selected from the group of synthetic, semi-synthetic and natural oils, e.g. B. olive oil, Sunflower oil, soybean oil, peanut oil, rapeseed oil, almond oil, palm oil, coconut oil, palm kernel oil and the like more.
Auch beliebige Abmischungen solcher Öl- und Wachskomponenten sind vorteilhaft im Sinne der vorliegenden Erfindung einzusetzen. Es kann auch gegebenenfalls vorteilhaft sein, Wachse, beispielsweise Bienenwachs und seine Derivate, als alleinige Lipidkomponente der Ölphase einzusetzen. Any mixtures of such oil and wax components are also advantageous use in the sense of the present invention. It can also if necessary be advantageous, as waxes, for example beeswax and its derivatives use only lipid component of the oil phase.
Vorteilhaft wird die Ölphase gewählt aus der Gruppe 2-Ethylhexylisostearat, Octyldodecanol, Isotridecylisononanoat, Isoeicosan, 2-Ethylhexylcocoat, C12-15 -Alkylbenzoat, Capryl-Caprinsäure-triglycerid und Dicaprylylether. The oil phase is advantageously selected from the group consisting of 2-ethylhexyl isostearate, octyldodecanol, isotridecyl isononanoate, isoeicosane, 2-ethylhexyl cocoate, C 12-15 alkyl benzoate, caprylic capric acid triglyceride and dicaprylyl ether.
Besonders vorteilhaft sind Mischungen aus C12-15-Alkylbenzoat und 2-Ethylhexylisostearat, Mischungen aus C12-15-Alkylbenzoat und Isotridecylisononanoat sowie Mischungen aus C12-15-Alkylbenzoat, 2-Ethylhexylisostearat und Isotridecylisononanoat. Mixtures of C 12-15 alkyl benzoate and 2-ethylhexyl isostearate, mixtures of C 12-15 alkyl benzoate and isotridecyl isononanoate and mixtures of C 12-15 alkyl benzoate, 2-ethyl hexyl isostearate and isotridecyl isononanoate are particularly advantageous.
Von den Kohlenwasserstoffen sind Paraffinöl, Squalan und Squalen vorteilhaft im Sinne der vorliegenden Erfindung zu verwenden. Of the hydrocarbons, paraffin oil, squalane and squalene are advantageous in To use sense of the present invention.
Vorteilhaft kann die Ölphase ferner einen Gehalt an cyclischen oder linearen Silikonölen aufweisen oder vollständig aus solchen Ölen bestehen, wobei allerdings bevorzugt wird, außer dem Silikonöl oder den Silikonölen einen zusätzlichen Gehalt an anderen Ölphasenkomponenten zu verwenden. The oil phase can also advantageously have a cyclic or linear content Have silicone oils or consist entirely of such oils, although an additional content is preferred in addition to the silicone oil or the silicone oils to be used on other oil phase components.
Vorteilhaft wird Cyclomethicon (Octamethylcyclotetrasiloxan) als erfindungsgemäß zu verwendendes Silikonöl eingesetzt. Aber auch andere Silikonöle sind vorteilhaft im Sinne der vorliegenden Erfindung zu verwenden, beispielsweise Hexamethylcyclotrisiloxan, Polydimethylsiloxan, Poly(methylphenylsiloxan). Cyclomethicone (octamethylcyclotetrasiloxane) is advantageous as according to the invention silicone oil to be used. But other silicone oils are also beneficial to use in the sense of the present invention, for example Hexamethylcyclotrisiloxane, polydimethylsiloxane, poly (methylphenylsiloxane).
Besonders vorteilhaft sind Mischungen aus Cyclomethicon und Isotridecylisononanoat sowie aus Cyclomethicon und 2-Ethylhexylüsostearat. Mixtures of cyclomethicone and Isotridecyl isononanoate as well as from cyclomethicone and 2-ethylhexyl isostearate.
Die wässrige Phase der erfindungsgemäßen Zubereitungen enthält gegebenenfalls
vorteilhaft:
- - Alkohole, Diole oder Polyole niedriger C-Zahl sowie deren Ether, vorzugsweise Ethanol, Isopropanol, Propylenglykol, Glycerin. Ethylenglykol, Ethylenglykolmonoethyl- oder -monobutylether, Propylenglykolmonomethyl, -mono-ethyl- oder -monobutylether, Diethylenglykolmonomethyl- oder -monoethylether und analoge Produkte, ferner Alkohole niedriger C-Zahl, z. B. Ethanol, Isopropanol, 1,2-Propandiol, Glycerin sowie insbesondere ein oder mehrere Verdickungsmittel, welches oder welche vorteilhaft gewählt werden können aus der Gruppe Siliciumdioxid, Aluminiumsilikate, Polysaccharide bzw. deren Derivate, z. B. Hyaluronsäure, Xanthangummi, Hydroxypropylmethylcellulose, besonders vorteilhaft aus der Gruppe der Polyacrylate, bevorzugt ein Polyacrylat aus der Gruppe der sogenannten Carbopole, beispielsweise Carbopole der Typen 980, 981, 1382. 2984, 5984, jeweils einzeln oder in Kombination.
- - Alcohols, diols or polyols of low C number and their ethers, preferably ethanol, isopropanol, propylene glycol, glycerin. Ethylene glycol, ethylene glycol monoethyl or monobutyl ether, propylene glycol monomethyl, mono ethyl or monobutyl ether, diethylene glycol monomethyl or monoethyl ether and similar products, furthermore alcohols of low C number, e.g. As ethanol, isopropanol, 1,2-propanediol, glycerol and in particular one or more thickeners, which or which can advantageously be selected from the group consisting of silicon dioxide, aluminum silicates, polysaccharides or their derivatives, e.g. B. hyaluronic acid, xanthan gum, hydroxypropylmethyl cellulose, particularly advantageously from the group of polyacrylates, preferably a polyacrylate from the group of so-called carbopoles, for example carbopoles of types 980, 981, 1382, 2984, 5984, each individually or in combination.
Vorteilhafterweise enthalten die erfindungsgemäßen kosmetischen und dermatologischen Zubereitungen zusätzlich zu den verwendeten UV-A-, UV-B und/oder Breitbandfiltern, wenngleich nicht zwingend, anorganische Pigmente auf Basis von Metalloxiden und/oder anderen in Wasser schwerlöslichen oder unlöslichen Metallverbindungen, insbesondere der Oxide des Titans (TiO2), Zinks (ZnO), Eisens (z. B. Fe2O3), Zirkoniums (ZrO2), Siliciums (SiO2), Mangans (z. B. MnO), Aluminiums (Al2O3), Cers (z. B. Ce2O3), Mischoxiden der entsprechenden Metalle sowie Abmischungen aus solchen Oxiden. Diese Pigmente sind röntgenamorph oder nicht- röntgenamorph. Besonders bevorzugt handelt es sich um Pigmente auf der Basis von TiO2. The cosmetic and dermatological preparations according to the invention advantageously contain, in addition to the UV-A, UV-B and / or broadband filters used, although not absolutely, inorganic pigments based on metal oxides and / or other metal compounds which are sparingly soluble or insoluble in water, in particular the oxides of Titanium (TiO 2 ), zinc (ZnO), iron (e.g. Fe 2 O 3 ), zirconium (ZrO 2 ), silicon (SiO 2 ), manganese (e.g. MnO), aluminum (Al 2 O 3 ), Cers (e.g. Ce 2 O 3 ), mixed oxides of the corresponding metals and mixtures of such oxides. These pigments are X-ray amorphous or non-X-ray amorphous. Pigments based on TiO 2 are particularly preferred.
Röntgenamorphe Oxidpigmente sind Metalloxide oder Halbmetalloxide, welche bei Röntgenbeugungsexperimenten keine oder keine erkenntliche Kristallstruktur erkennen lassen. Oftmals sind solche Pigmente durch Flammenreaktion erhältlich, beispielsweise dadurch, dass ein Metall- oder Halbmetallhalogenid mit Wasserstoff und Luft (oder reinem Sauerstoff) in einer Flamme umgesetzt wird. X-ray amorphous oxide pigments are metal oxides or semimetal oxides, which contribute to X-ray diffraction experiments no or no discernible crystal structure reveal. Such pigments are often obtainable by flame reaction, for example in that a metal or semimetal halide with hydrogen and air (or pure oxygen) is reacted in a flame.
In kosmetischen, dermatologischen oder pharmazeutischen Formulierungen werden röntgenamorphe Oxidpigmente als Verdickungs- und Thixotropierungsmittel, Fließhilfsmittel zur Emulsions- und Dispersionsstabilisierung und als Trägersubstanz (beispielsweise zur Volumenerhöhung von feinteiligen Pulvern oder Pudern) eingesetzt. In cosmetic, dermatological or pharmaceutical formulations X-ray amorphous oxide pigments as thickening and thixotropic agents, Flow aid for stabilizing emulsions and dispersions and as a carrier (for example to increase the volume of finely divided powders or powders) used.
Bekannte und in der kosmetischen oder dermatologischen Galenik oftmals verwendete röntgenamorphe Oxidpigmente sind die Siliciumoxide des Typs Aerosil® (CAS- Nr. 7631-85-9). Aerosile® erhältlich von der Gesellschaft DEGUSSA, zeichnen sich durch geringe Partikelgröße (z. B. zwischen 5 und 40 nm) aus, wobei die Partikel als kugelförmige Teilchen sehr einheitlicher Abmessung anzusehen sind. Makroskopisch sind Aerosile® als lockere, weiße Pulver erkenntlich. Im Sinne der vorliegenden Erfindung sind röntgenamorphe Siliciumdioxidpigmente besonders vorteilhaft, und unter diesen gerade solche des Aerosil®-Typs bevorzugt. Well-known and often in cosmetic or dermatological galenics X-ray amorphous oxide pigments used are the silicon oxides of the type Aerosil® (CAS- No. 7631-85-9). Aerosile® available from DEGUSSA company stand out by small particle size (e.g. between 5 and 40 nm), the particles being spherical particles of very uniform dimensions can be seen. macroscopic Aerosile® are recognizable as loose, white powder. In the sense of the present X-ray amorphous silicon dioxide pigments are particularly advantageous, and among these, those of the Aerosil® type are preferred.
Vorteilhafte Aerosil®-Typen sind beispielsweise Aerosil® 0X50, Aerosil® 130, Aerosil® 150, Aerosil® 200, Aerosil® 300, Aerosil® 380, Aerosil® MQX 80, Aerosil® MOX 170, Aerosil® COK 84, Aerosil® R 202, Aerosil® R 805, Aerosil® R 812, Aerosil® R 972, Aerosil® R 974 und Aerosil® R976. Advantageous Aerosil® types are, for example, Aerosil® 0X50, Aerosil® 130, Aerosil® 150, Aerosil® 200, Aerosil® 300, Aerosil® 380, Aerosil® MQX 80, Aerosil® MOX 170, Aerosil® COK 84, Aerosil® R 202, Aerosil® R 805, Aerosil® R 812, Aerosil® R 972, Aerosil® R 974 and Aerosil® R976.
Erfindungsgemäß enthalten die kosmetischen oder dermatologischen Lichtschutzzubereitun-gen 0,1 bis 20 Gew.-%, vorteilhaft 0,5 bis 10 Gew.-%, ganz besonders bevorzugt 1 bis 5 Gew.-% röntgenamorphe Oxidpigmente. According to the invention contain cosmetic or dermatological Sunscreen preparations 0.1 to 20% by weight, advantageously 0.5 to 10% by weight, very particularly preferably 1 to 5% by weight of X-ray amorphous oxide pigments.
Die nicht-röntgenamorphen anorganischen Pigmente liegen erfindungsgemäß vorteilhaft in hydrophober Form vor, d. h., dass sie oberflächlich wasserabweisend behandelt sind. Diese Oberflächenbehandlung kann darin bestehen, dass die Pigmente nach an sich bekannten Verfahren mit einer dünnen hydrophoben Schicht versehen werden. Beispielsweise in Analogie zu DE-A 33 14 742 dargestellte hydrophobisierte Pigmente sind von Vorteil. The non-X-ray amorphous inorganic pigments are in accordance with the invention advantageously in hydrophobic form, d. that is, it's superficial water-repellent are treated. This surface treatment can consist of the Pigments according to known methods with a thin hydrophobic layer be provided. For example, shown in analogy to DE-A 33 14 742 Hydrophobized pigments are an advantage.
Vorteilhafte TiO2-Pigmente sind beispielsweise unter der Handelsbezeichnung T 805, vorteilhafte TiO2/Fe2O3Mischoxide unter der Handelsbezeichnung T 817 von der Firma Degussa erhältlich. Advantageous TiO 2 pigments are available, for example, under the trade name T 805, advantageous TiO 2 / Fe 2 O 3 mixed oxides under the trade name T 817 from Degussa.
Die Gesamtmenge an anorganischen Pigmenten, insbesondere hydrophilen und hydrophoben anorganischen Mikropigmenten in den fertigen kosmetischen oder dermatologischen Zubereitungen wird vorteilhaft aus dem Bereich von 0,1-30 Gew.-%, bevorzugt 0,1-10,0, insbesondere 0,5-6,0 Gew.-% gewählt, bezogen auf das Gesamtgewicht der Zubereitungen. The total amount of inorganic pigments, especially hydrophilic and hydrophobic inorganic micropigments in the finished cosmetic or dermatological preparations is advantageous from the range of 0.1-30% by weight, preferably 0.1-10.0, in particular 0.5-6.0% by weight, selected on the total weight of the preparations.
Ein zusätzlicher Gehalt an Antioxidantien in den erfindungsgemäßen kosmetischen und dermatologischen Zubereitungen ist im allgemeinen bevorzugt. Erfindungsgemäß können als günstige Antioxidantien alle für kosmetische und/oder dermatologische Anwendungen geeigneten oder gebräuchlichen Antioxidantien verwendet werden. An additional content of antioxidants in the cosmetic according to the invention and dermatological preparations are generally preferred. According to the invention, all of the cosmetic and / or dermatological applications suitable or customary antioxidants used become.
Vorteilhaft werden die Antioxidantien gewählt aus der Gruppe bestehend aus Aminosäuren (z. B. Glycin, Histidin, Tyrosin, Tryptophan) und deren Derivate, Imidazole (z. B. Urocaninsäure) und deren Derivate, Peptide wie D,L-Carnosin, D- Carnosin, L-Carnosin und deren Derivate (z. B. Anserin), Carotinoide, Carotine (z. B. a-Carotin, b-Carotin, Lycopin) und deren Derivate, Chlorogensäure und deren Derivate, Liponsäure und deren Derivate (z. B. Dihydroliponsäure), Aurothioglucose, Propylthiouracil und andere Ihiole (z. B. Thioredoxin, Glutathion, Cystein, Cystin, Cystamin und deren Glycosyl-, N-Acetyl-, Methyl-, Ethyl-, Propyl-, Amyl-, Butyl- und Lauryl-, Palmitoyl-, Oleyl-, y-Linoleyl-, Cholesteryl- und Glycerylester) sowie deren Salze, Dilaurylthiodipropionat, Distearylthiodipropionat, Thiodipropionsäure und deren Derivate (Ester, Ether, Peptide, Lipide, Nukleotide, Nukleoside und Salze), Phenolsäureamide phenolischer Benzylamine (z. B. Homovanillinsäure-, 3,4- Dihydroxyphenylessigsäure-, Ferulasäure-, Sinapinsäure-, Kaffeesäure-, Dihydroferulasäure-, Dihydrokaffeesäure-, Vanillomandelsäure- oder 3,4-Dihydroxymandelsäureamide des 3,4-Dihydroxybenzyl-, 2,3,4-Trihydroxy-benzyl- bzw. 3,4,5-Trihydroxybenzylamins) sowie Sulfoximinverbindungen (z. B. Buthioninsulfoximine, Homocysteinsulfoximin, Buthioninsulfone, Penta-, Hexa-, Heptathioninsulfoximin) in sehr geringen verträglichen Dosierungen, ferner (Metall)-Chelatoren (z. B. α- Hydroxyfettsäuren, Palmitinsäure, Phytinsäure, Lactoferrin), α-Hydroxysäuren (z. B. Citronensäure, Milchsäure, Apfelsäure), Huminsäure, Gallensäure, Gallenextrakte, Bilirubin, Biliverdin, EDTA, EGTA und deren Derivate, ungesättigte Fettsäuren und deren Derivate (z. B. γ-Linolensäure, Linolsäure, Ölsäure), Folsäure und deren Derivate, Ubichinon und Ubichinol und deren Derivate, Vitamin C und Derivate (z. B. Ascorbylpalmitat, Mg-Ascorbylphosphat, Ascorbylacetat), Tocopherole und Derivate (z. B. Vitamin-E-acetat), Vitamin A und Derivate (Vitamin-A-palmitat) sowie Koniferylbenzoat des Benzoeharzes, Rutinsäure und deren Derivate, α- Glycosylrutin, Ferulasäure, Furfurylidenglucitol, Carnosin, Butylhydroxytoluol, Butylhydroxyanisol, Nordihydroguajakharzsäure, Nordihydroguajaretsäure, Trihydroxybutyrophenon, Harnsäure und deren Derivate, Mannose und deren Derivate, Zink und dessen Derivate (z. B. ZnO, ZnSO4), Selen und dessen Derivate (z. B. Selenmethionin), Stilbene und deren Derivate (z. B. Stilbenoxid, trans- Stilbenoxid) und die erfindungsgemäß geeigneten Derivate (Salze, Ester, Ether, Zucker, Nukleotide, Nukleoside, Peptide und Lipide) dieser genannten Wirkstoffe. The antioxidants are advantageously selected from the group consisting of amino acids (e.g. glycine, histidine, tyrosine, tryptophan) and their derivatives, imidazoles (e.g. urocanic acid) and their derivatives, peptides such as D, L-carnosine, D- Carnosine, L-carnosine and their derivatives (e.g. anserine), carotenoids, carotenes (e.g. a-carotene, b-carotene, lycopene) and their derivatives, chlorogenic acid and its derivatives, lipoic acid and its derivatives (e.g. B. dihydrolipoic acid), aurothioglucose, propylthiouracil and other ihiols (e.g. thioredoxin, glutathione, cysteine, cystine, cystamine and their glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl and Lauryl, palmitoyl, oleyl, y-linoleyl, cholesteryl and glyceryl esters) and their salts, dilauryl thiodipropionate, distearyl thiodipropionate, thiodipropionic acid and their derivatives (esters, ethers, peptides, lipids, nucleotides, nucleosides and salts), phenolic acid amides phenolic acid amines phenolic (e.g. homovanillic acid, 3,4-dihydroxyphenylessi gic acid, ferulic acid, sinapic acid, caffeic acid, dihydroferulic acid, dihydrocaffeic acid, vanillomandelic acid or 3,4-dihydroxymandelic acid amides of 3,4-dihydroxybenzyl-, 2,3,4-trihydroxy-benzyl- or 3,4, 5-trihydroxybenzylamine) and sulfoximine compounds (e.g. B. Buthioninsulfoximine, Homocysteinsulfoximin, Buthioninsulfone, Penta-, Hexa-, Heptathioninsulfoximin) in very low tolerable doses, further (metal) chelators (z. B. α-hydroxy fatty acids, palmitic acid, phytic acid, lactoferrin), α-hydroxy acids (z. B. citric acid, lactic acid, malic acid), humic acid, bile acid, bile extracts, bilirubin, biliverdin, EDTA, EGTA and their derivatives, unsaturated fatty acids and their derivatives (e.g. γ-linolenic acid, linoleic acid, oleic acid), folic acid and their derivatives, Ubiquinone and ubiquinol and their derivatives, vitamin C and derivatives (e.g. ascorbyl palmitate, Mg ascorbyl phosphate, ascorbyl acetate), tocopherols and derivatives (e.g. vitamin E acetate), vitamin A and derivatives (vitamin A palmitate ) and coniferyl benzoate of benzoin, rutinic acid and its derivatives, α-glycosyl rutin, ferulic acid, furfurylidene glucitol, carnosine, butylated hydroxytoluene, butylated hydroxyanisole, nordihydroguajak resin acid, nordihydroguajaretic acid, T. rihydroxybutyrophenone, uric acid and its derivatives, mannose and its derivatives, zinc and its derivatives (e.g. B. ZnO, ZnSO 4 ), selenium and its derivatives (z. B. selenomethionine), stilbenes and their derivatives (z , Nucleosides, peptides and lipids) of these active ingredients.
Die Menge der vorgenannten Antioxidantien (eine oder mehrere Verbindungen) in den erfindungsgemäßen Zubereitungen beträgt vorzugsweise 0,001 bis 30 Gew.-%, besonders bevorzugt 0,05-20 Gew.-%, insbesondere 1-10 Gew.-%, bezogen auf das Gesamtgewicht der Zubereitung. The amount of the aforementioned antioxidants (one or more compounds) in the preparations according to the invention are preferably 0.001 to 30% by weight, particularly preferably 0.05-20% by weight, in particular 1-10% by weight, based on the Total weight of the preparation.
Sofern Vitamin E und/oder dessen Derivate das oder die Antioxidantien darstellen, ist es vorteilhaft, deren jeweilige Konzentrationen aus dem Bereich von 0,001-10 Gew.-%, bezogen auf das Gesamtgewicht der Formulierung, zu wählen. If vitamin E and / or its derivatives represent the antioxidant (s), it is advantageous to have their respective concentrations in the range of 0.001-10 wt .-%, based on the total weight of the formulation to choose.
Sofern Vitamin A, bzw. Vitamin-A-Derivate, bzw. Carotine bzw. deren Derivate das oder die Antioxidantien darstellen, ist vorteilhaft, deren jeweilige Konzentrationen aus dem Bereich von 0,001-10 Gew.-%, bezogen auf das Gesamtgewicht der Formulierung, zu wählen. If vitamin A, or vitamin A derivatives, or carotenes or their derivatives, the or the antioxidants are advantageous, their respective concentrations from the range of 0.001-10% by weight, based on the total weight of the Wording to choose.
Weiterhin können in den kosmetischen Zubereitungen auch Hautaufhellungsmittel eingesetzt werden. Bevorzugt können dabei als Hautaufhellungsmittel Benzaldoxime mit mindestens einer aromatischen Hydroxy- oder Alkoxygruppe, benzokondensierte oder heterocyclisch kondensierte 2-Hydrazino-1,3-thiazole, 2-Thio-1,3,4-heterodiazole, deren anionischen oder kationischen Salze sowie Gemische derselben, Kojisäure, Kojisäurederivate, Ascorbinsäure, Ascorbinsäurederivate, Hydrochinon, Hydrochinon-derivate, schwefelhaltigen Moleküle (z. B. Glutathion oder Cystein) oder andere synthetische oder natürliche Wirkstoffe zur Hautaufhellung zum Einsatz gelangen, wobei letztere auch in Form eines Extrakts aus Pflanzen (z. B. Tocopherole und Derivate, Arbutin [z. B. aus Bearberry-Extrakt], Aloesin [z. B. aus Aloe-Extrakt], Grapefruit-Extrakt und Reis-Extrakt) verwendet werden können. In addition, skin lightening agents can also be used in the cosmetic preparations be used. Benzaldoximes can preferably be used as skin lightening agents with at least one aromatic hydroxy or alkoxy group, benzo-condensed or heterocyclically fused 2-hydrazino-1,3-thiazoles, 2-thio-1,3,4-heterodiazoles, their anionic or cationic salts and mixtures thereof, Kojic acid, kojic acid derivatives, ascorbic acid, ascorbic acid derivatives, hydroquinone, Hydroquinone derivatives, sulfur-containing molecules (e.g. glutathione or cysteine) or other synthetic or natural skin lightening agents arrive, the latter also in the form of an extract from plants (e.g. tocopherols and derivatives, arbutin [e.g. B. from Bearberry extract], Aloesin [z. B. from aloe extract], Grapefruit extract and rice extract) can be used.
Vorteilhafterweise enthalten die erfindungsgemäßen kosmetischen und dermatologischen Zubereitungen zusätzlich auch Komplexbildner (z. B. aus der Klasse der Amino-polycarbonsäuren, aromatischen Hydroxy-und Amino-Derivate, Enolate). The cosmetic and dermatological preparations also include complexing agents (e.g. from the class of Amino-polycarboxylic acids, aromatic hydroxy and amino derivatives, enolates).
Außerdem können die kosmetischen und dermatologischen Zubereitungen auch Anti- inflammatorische Mittel aufweisen, die aus den Verbindungsklassen der Salicyl-, Essig- und Propionsäure-Derivate, den Pyrazolen, Fenamten und Oxicamen stammen. In addition, the cosmetic and dermatological preparations can also have inflammatory agents which consist of the compound classes of salicylic, Acetic and propionic acid derivatives, the pyrazoles, fenams and oxicams come.
Ferner können die kosmetischen und dermatologischen Zubereitungen Hilfsstoffe mit Kühl- und Erfrischungseffekt, wie z. B. Menthol und hiervon abgeleitete Derivate, enthalten. Furthermore, the cosmetic and dermatological preparations can contain adjuvants Cooling and refreshing effect, such as B. menthol and derivatives derived therefrom, contain.
Eine umfassende Beschreibung der in kosmetischen Mitteln eingesetzten Roh- und Wirkstoffe ist in DE-A 199 19 630 dargestellt. A comprehensive description of the raw and used in cosmetic products Active ingredients are shown in DE-A 199 19 630.
Die jeweils einzusetzenden Mengen an kosmetischen oder dermatologischen Hilfs- und Trägerstoffen und Parfüm können in Abhängigkeit von der Art des jeweiligen Produktes vom Fachmann durch einfaches Ausprobieren leicht ermittelt werden. The amounts of cosmetic or dermatological auxiliary and carriers and perfume can vary depending on the type of each Product can be easily determined by a specialist simply by trying it out.
Die Acrylnitril-Derivate der Formel (I) können einzeln oder in Mischung in den entsprechenden Zubereitungen eingesetzt werden; man kann sie auch in Kombination mit UV-Absorbern anderer Substanzklassen oder auch mit diesen in beliebigen Gemischen untereinander einsetzen. Die Liste der nachfolgend genannten UV-Absorber, die im Sinne der vorliegenden Erfindung eingesetzt werden können, soll selbstverständlich nicht limitierend sein.
- - p-Aminobenzoesäure
- - p-Aminobenzoesäureethylester
- - p-Dimethylaminobenzoesäure-2-ethylhexylester
- - p-Aminobenzoesäureethylester
- - p-Aminobenzoesäureglycerinester
- - Salicylsäure-homomenthylester (Homosalate) (Neo Heliopan®HMS)
- - Salicylsäure-2-ethylhexylester (Neo Heliopan®OS)
- - Triethanolaminsalicylat
- - 4-Isopropylbenzylsalicylat
- - Anthranilsäurementhylester (Neo Heliopan®MA)
- - Diisopropylzimtsäureethylester
- - p-Methoxyzimtsäure-2-ethylhexylester (Neo Heliopan®AV)
- - Diisopropylzimtsäuremethylester
- - p-Methoxyzimtsäureisoamylester (Neo Heliopan®E 1000)
- - p-Methoxyzimtsäure-diethanolaminsalz
- - p-Methoxyzimtsäure-isopropylester
- - 2-Ethylhexyl-2-cyano-3,3-diphenylacrylat (Neo Heliopan®303)
- - Ethyl-2-cyano-3,3'-diphenylacrylat
- - 2-Phenylbenzimidazolsulfonsäure und Salze (Neo Heliopan®Hydro)
- - 3-(4'-Trimethylammonium)-benzyliden-bornan-2-on-methylsulfat
- - Terephthalyliden-dibornansulfonsäure und Salze (Mexoryl®SX)
- - 4-t-Butyl-4'-methoxy-dibenzoylmethan (Avobenzon)/(Neo Heliopan®357)
- - β-Imidazol-4(5)-acrylsäure (Urocaninsäure)
- - 2-Hydroxy-4-methoxybenzophenon (Neo Heliopan®BB)
- - 2-Hydroxy-4-methoxybenzophenon-5-sulfonsäure
- - Dihydroxy-4-methoxybenzophenon
- - 2,4-Dihydroxybenzophenon
- - Tetrahydroxybenzophenon
- - 2,2'-Dihydroxy-4,4'-dimethoxybenzophenon
- - 2-Hydroxy-4-n-octoxybenzophenon
- - 2-Hydroxy-4-methoxy-4'-methylbenzophenon
- - 3-(4'-Sulfo)benzyliden-bornan-2-on und Salze
- - 3-(4'-Methylbenzyliden)-d,l-campher (Neo Heliopan®MBC)
- - 3-Benzyliden-d,l-campher
- - 4-Isopropyldibenzoylmethan
- - 2,4,6-Trianilino-(p-carbo-2'-ethylhexyl-1'-oxy)-1,3,5-triazin
- - Phenylen-bis-benzimidazyl-tetrasulfonsäure-dinatriumsalz (Neo Heliopan®AP)
- - 2,2'-(1,4-Phenylen)-bis-(1H-benzimidazol-4,6-disulfonsäure), Mononatriumsalz
- - N-[(2 und 4)-[2-(oxoborn-3-yliden)methyl]benzyl]-acrylamid-Polymer
- - Phenol, 2-(2H-benzotriazol-2-yl)-4-methyl-6-(2-methyl-3(1,3,3,3-tetramethyl-1- (trimethylsilyl)-oxy)-disiloxyanyl)-propyl), (Mexoryl®XL)
- - 4,4'-[(6-[4-(1,1-Dimethyl)-aminocarbonyl)-phenylamino]-1,3,5-triazin-2,4- diyl)diimino]-bis-(benzoesäure-2-ethylhexylester) (Uvasorb®HEB)
- - 2,2'-Methylen-bis-(6-(2H-benztriazol-2-yl)-4-1,1,3,3-tetramethylbutyl)-phenol), (Tinosorb®M)
- - 2,4-bis-[4-(2-ethylhexyloxy)-2-hydroxyphenyl]-1,3,5-triazin
- - Benzylidenmalonat-Polysiloxan (Parsol®SLX)
- - Glyceryl-ethylhexanoat-dimethoxycinnamat
- - Dinatrium-2,2'-dihydroxy-4,4'-dimethoxy-5,5'-disulfo-benzophenon
- - Dipropylenglykolsalicylat
- - Natrium-hydroxymethoxybenzophenon-sulfonat
- - 4,4',4-(1,3,5-Triazin-2,4,6-triyltriimino)-tris-benzoesäure-tris(2-ethylhexylester) (Uvinul®T150)
- - 2,4-Bis-[{(4-(2-Ethyl-hexyloxy)-2-hydroxy}-phenyl]-6-(4-methoxyphenyl)-1,3,5- triazin, (Tinosorb®S)
- - 2,4-Bis-[{(4-(3-sulfonato)-2-hydroxy-propyloxy)-2-hydroxy}-phenyl]-6-(4-methoxyphenyl)-1,3,5-triazin-Natriumsalz
- - 2,4-Bis-[{(3-(2-Propyloxy)-2-hydroxy-propyloxy)-2-hydroxy}-phenyl]-6-(4- methoxy-phenyl)-1,3,5-triazin
- - 2,4-Bis-[{4-(2-Ethyl-hexyloxy)-2-hydroxy}-phenyl]-6-[4-(2-methoxyethylcarbonyl)-phenylamino]-1,3,5-triazin
- - 2,4-Bis-[{4-(3-(2-propyloxy)-2-hydroxy-propyloxy)-2-hydroxy}-phenyl]-6-[4-(2- ethylcarboxyl)-phenylamino]-1,3,5-triazin
- - 2,4-Bis-[{4-(2-Ethyl-hexyloxy)-2-hydroxy}-phenyl]-6-(1-methyl-pyrrol-2-yl-)- 1,3,5-triazin
- - 2,4-Bis-[{4-tris-(trimethylsiloxy-silylpropyloxy)-2-hydroxy}-phenyl]-6-(4-methoxyphenyl)-1,3,5-triazin
- - 2,4-Bis-[{4-(2"-Methylpropenyloxy)-2-hydroxy}-phenyl]-6-(4-methoxyphenyl)- 1,3,5-triazin
- - 2,4-Bis-[{4-(1',1',1',3'5',5',5'-Heptamethylsiloxy-2"-methyl-propyloxy)-2-hydroxy}-phenyl]-6-(4-methoxyphenyl)-1,3,5-triazin
- - p-aminobenzoic acid
- - ethyl p-aminobenzoate
- - 2-ethylhexyl p-dimethylaminobenzoate
- - ethyl p-aminobenzoate
- p-aminobenzoic acid glycerol ester
- - Salicylic acid homomethyl ester (homosalates) (Neo Heliopan®HMS)
- - 2-ethylhexyl salicylic acid (Neo Heliopan®OS)
- - triethanolamine salicylate
- - 4-isopropylbenzyl salicylate
- - Anthranile acid ethyl ester (Neo Heliopan®MA)
- - Ethyl diisopropyl cinnamate
- - 2-ethylhexyl p-methoxycinnamate (Neo Heliopan®AV)
- - methyl diisopropyl cinnamate
- - p-methoxycinnamic acid isoamyl ester (Neo Heliopan®E 1000)
- p-methoxycinnamic acid diethanolamine salt
- - Isopropyl p-methoxycinnamate
- - 2-ethylhexyl-2-cyano-3,3-diphenyl acrylate (Neo Heliopan®303)
- - ethyl 2-cyano-3,3'-diphenyl acrylate
- - 2-phenylbenzimidazole sulfonic acid and salts (Neo Heliopan®Hydro)
- - 3- (4'-Trimethylammonium) benzylidene-bornan-2-one methyl sulfate
- - Terephthalylidene-dibornanesulfonic acid and salts (Mexoryl®SX)
- - 4-t-Butyl-4'-methoxy-dibenzoylmethane (Avobenzon) / (Neo Heliopan®357)
- - β-imidazole-4 (5) -acrylic acid (urocanic acid)
- - 2-hydroxy-4-methoxybenzophenone (Neo Heliopan®BB)
- - 2-Hydroxy-4-methoxybenzophenone-5-sulfonic acid
- - Dihydroxy-4-methoxybenzophenone
- - 2,4-dihydroxybenzophenone
- - tetrahydroxybenzophenone
- - 2,2'-dihydroxy-4,4'-dimethoxybenzophenone
- - 2-Hydroxy-4-n-octoxybenzophenone
- - 2-Hydroxy-4-methoxy-4'-methylbenzophenone
- - 3- (4'-Sulfo) benzylidene-bornan-2-one and salts
- - 3- (4'-Methylbenzyliden) -d, l-camphor (Neo Heliopan®MBC)
- - 3-benzylidene-d, l-camphor
- - 4-isopropyldibenzoylmethane
- - 2,4,6-trianilino- (p-carbo-2'-ethylhexyl-1'-oxy) -1,3,5-triazine
- - Phenylene-bis-benzimidazyl-tetrasulfonic acid disodium salt (Neo Heliopan®AP)
- - 2,2 '- (1,4-phenylene) bis (1H-benzimidazole-4,6-disulfonic acid), monosodium salt
- - N - [(2 and 4) - [2- (oxoborn-3-ylidene) methyl] benzyl] acrylamide polymer
- Phenol, 2- (2H-benzotriazol-2-yl) -4-methyl-6- (2-methyl-3 (1,3,3,3-tetramethyl-1- (trimethylsilyl) -oxy) -disiloxyanyl) - propyl), (Mexoryl®XL)
- - 4,4 '- [(6- [4- (1,1-dimethyl) aminocarbonyl) phenylamino] -1,3,5-triazine-2,4-diyl) diimino] bis (benzoic acid-2 -ethylhexyl ester) (Uvasorb®HEB)
- - 2,2'-methylene-bis- (6- (2H-benzotriazol-2-yl) -4-1,1,3,3-tetramethylbutyl) phenol), (Tinosorb®M)
- - 2,4-bis- [4- (2-ethylhexyloxy) -2-hydroxyphenyl] -1,3,5-triazine
- - benzylidene malonate polysiloxane (Parsol®SLX)
- Glyceryl ethylhexanoate dimethoxycinnamate
- Disodium 2,2'-dihydroxy-4,4'-dimethoxy-5,5'-disulfo-benzophenone
- - Dipropylene glycol salicylate
- Sodium hydroxymethoxybenzophenone sulfonate
- - 4,4 ', 4- (1,3,5-triazine-2,4,6-triyltriimino) tris-benzoic acid tris (2-ethylhexyl ester) (Uvinul®T150)
- - 2,4-bis - [{(4- (2-ethylhexyloxy) -2-hydroxy} phenyl] -6- (4-methoxyphenyl) -1,3,5- triazine, (Tinosorb®S)
- - 2,4-bis - [{(4- (3-sulfonato) -2-hydroxypropyloxy) -2-hydroxy} phenyl] -6- (4-methoxyphenyl) -1,3,5-triazine sodium salt
- - 2,4-bis - [{(3- (2-propyloxy) -2-hydroxypropyloxy) -2-hydroxy} phenyl] -6- (4-methoxyphenyl) -1,3,5-triazine
- - 2,4-bis - [{4- (2-ethylhexyloxy) -2-hydroxy} phenyl] -6- [4- (2-methoxyethylcarbonyl) phenylamino] -1,3,5-triazine
- - 2,4-bis - [{4- (3- (2-propyloxy) -2-hydroxypropyloxy) -2-hydroxy} phenyl] -6- [4- (2-ethylcarboxyl) phenylamino] -1 , 3,5-triazine
- - 2,4-bis - [{4- (2-ethylhexyloxy) -2-hydroxy} phenyl] -6- (1-methyl-pyrrol-2-yl -) - 1,3,5-triazine
- - 2,4-bis - [{4-tris (trimethylsiloxysilylpropyloxy) -2-hydroxy} phenyl] -6- (4-methoxyphenyl) -1,3,5-triazine
- - 2,4-bis - [{4- (2 "-methylpropenyloxy) -2-hydroxy} phenyl] -6- (4-methoxyphenyl) - 1,3,5-triazine
- - 2,4-bis - [{4- (1 ', 1', 1 ', 3'5', 5 ', 5'-heptamethylsiloxy-2 "-methyl-propyloxy) -2-hydroxy} phenyl] - 6- (4-methoxyphenyl) -1,3,5-triazine
Besonders geeignete UV-Absorber sind:
- - p-Aminobenzoesäure
- - 3-(4'-Trimethylammonium)-benzyliden-bornan-2-on-methylsulfat
- - Salicylsäure-homomenthylester (Neo Heliopan®HMS)
- - 2-Hydroxy-4-methoxy-benzophenon (Neo Heliopan®BB)
- - 2-Phenylbenzimidazolsulfonsäure (Neo Heliopan®Hydro)
- - Terephthalyliden-dibornansulfonsäure und Salze (Mexoryl®SX)
- - 4-tert.-Butyl-4'-methoxydibenzoylmethan (Neo Heliopan®357)
- - 3-(4'-Sulfo)benzyliden-bornan-2-on und Salze
- - 2-Ethylhexyl-2-cyano-3,3-diphenylacrylat (Neo Heliopan®303)
- - N-[(2 und 4)-[2-(oxoborn-3-yliden)methyl]benzyl]-acrylamid-Polymer
- - p-Methoxyzimtsäure-2-ethylhexylester (Neo Heliopan®AV)
- - p-Aminobenzoesäure-ethylester
- - p-Methoxyzimtsäure-isoamylester (Neo Heliopan®E1000)
- - 2,4,6-Trianilino-(p-carbo-2'-ethylhexyl-1'-oxy)-1,3,5-triazin (Uvinul®T150)
- - Phenol, 2-(2H-benzotriazol-2-yl)-4-methyl-6-(2-methyl-3(1,3,3,3-tetramethyl-1- (trimethylsilyl)-oxy)-disiloxyanyl)-propyl), (Mexoryl®XL)
- - 4,4'-[(6-[4-(1,1-Dimethyl)-aminocarbonyl)-phenylamino]-1,3,5-triazin-2,4-diyl)- diimino]-bis-(benzoesäure-2-ethylhexylester), (UvasorbHEB)
- - 3-(4'-Methylbenzyliden)-d,l-campher (Neo Helipan®MBC)
- - 3-Benzylidencampher
- - Salicylsäure-2-ethylhexylester (Neo Helipan®OS)
- - 4-Dimethylaminobenzoesäure-2-ethylhexylester (Padimate O)
- - Hydroxy-4-methoxy-benzophenon-5-sulfonsäure und Na-Salz
- - 2,2'-Methylen-bis-(6-(2H-benztriazol-2-yl)-4-1,1,3,3-tetramethylbutyl)-phenol), (Tinosorb®M)
- - Phenylen-bis-benzimidazyl-tetrasulfonsäure-dinatriumsalz (Neo Heliopan®AP)
- - 2,4-Bis-[{(4-(2-Ethyl-hexyloxy)-2-hydroxy}-phenyl]-6-(4-methoxyphenyl)-1,3,5- triazin, (Tinosorb®S)
- - Benzylidenmalonat-Polysiloxan (Parsol®SLX)
- - Menthylanthranilat (Neo Heliopan®MA).
- - p-aminobenzoic acid
- - 3- (4'-Trimethylammonium) benzylidene-bornan-2-one methyl sulfate
- - Salicylic acid homomethyl ester (Neo Heliopan®HMS)
- - 2-hydroxy-4-methoxy-benzophenone (Neo Heliopan®BB)
- - 2-phenylbenzimidazole sulfonic acid (Neo Heliopan®Hydro)
- - Terephthalylidene-dibornanesulfonic acid and salts (Mexoryl®SX)
- - 4-tert-butyl-4'-methoxydibenzoylmethane (Neo Heliopan®357)
- - 3- (4'-Sulfo) benzylidene-bornan-2-one and salts
- - 2-ethylhexyl-2-cyano-3,3-diphenyl acrylate (Neo Heliopan®303)
- - N - [(2 and 4) - [2- (oxoborn-3-ylidene) methyl] benzyl] acrylamide polymer
- - 2-ethylhexyl p-methoxycinnamate (Neo Heliopan®AV)
- - ethyl p-aminobenzoate
- - p-methoxycinnamic acid isoamyl ester (Neo Heliopan®E1000)
- - 2,4,6-trianilino- (p-carbo-2'-ethylhexyl-1'-oxy) -1,3,5-triazine (Uvinul®T150)
- Phenol, 2- (2H-benzotriazol-2-yl) -4-methyl-6- (2-methyl-3 (1,3,3,3-tetramethyl-1- (trimethylsilyl) -oxy) -disiloxyanyl) - propyl), (Mexoryl®XL)
- - 4,4 '- [(6- [4- (1,1-dimethyl) aminocarbonyl) phenylamino] -1,3,5-triazine-2,4-diyl) - diimino] -bis- (benzoic acid- 2-ethylhexyl ester), (UvasorbHEB)
- - 3- (4'-methylbenzylidene) -d, l-camphor (Neo Helipan®MBC)
- - 3-benzylidene camphor
- - 2-ethylhexyl salicylic acid (Neo Helipan®OS)
- 2-ethylhexyl 4-dimethylaminobenzoate (Padimate O)
- - Hydroxy-4-methoxy-benzophenone-5-sulfonic acid and Na salt
- - 2,2'-methylene-bis- (6- (2H-benzotriazol-2-yl) -4-1,1,3,3-tetramethylbutyl) phenol), (Tinosorb®M)
- - Phenylene-bis-benzimidazyl-tetrasulfonic acid disodium salt (Neo Heliopan®AP)
- - 2,4-bis - [{(4- (2-ethylhexyloxy) -2-hydroxy} phenyl] -6- (4-methoxyphenyl) -1,3,5- triazine, (Tinosorb®S)
- - benzylidene malonate polysiloxane (Parsol®SLX)
- - menthyl anthranilate (Neo Heliopan®MA).
Es kann auch von Vorteil sein, polymergebundene oder polymere UV-Absorber in Zubereitungen gemäß der vorliegenden Erfindung zu verwenden, insbesondere solche, wie sie in WO 92/20690 beschrieben werden. It can also be advantageous to use polymer-bound or polymeric UV absorbers To use preparations according to the present invention, in particular those as described in WO 92/20690.
Die Aufzählung der genannten UV-Filter, die im Sinne der vorliegenden Erfindung eingesetzt werden können, soll selbstverständlich nicht limitierend sein. The enumeration of the UV filters mentioned in the sense of the present invention of course, should not be limiting.
Die Gesamtmenge aller (einfach und mehrfach sulfonierter) wasserlöslichen UV- Filtersubstanzen in den fertigen kosmetischen oder dermatologischen Zubereitungen, beispielsweise an Phenylen-bis-benzimidazyl-tetrasulfonsäure-dinatriumsalz bzw. deren Salzen und/oder die entsprechende Disulfonsäure bzw. deren Salzen und/oder 2-Phenylbenzimidazol-5-sulfonsäure bzw. deren Salzen und/oder 2-Hydroxy-4-methoxybenzophenon-5-sulfonsäure bzw. deren Salzen und/oder 4-(2-Oxo-3-bornylidenmethyl)-benzolsulfonsäure bzw. deren Salzen und/oder 2-Methyl-5-(2-oxo-3- bornyliden-methyl)-benzolsulfonsäure bzw. deren Salzen und/oder Benzol-1,4-di-(2- oxo-3-bornylidenmethyl)-10-sulfonsäure bzw. deren Salzen, wird vorteilhaft aus dem Bereich von 0,1 bis 10,0 Gew.-%, bevorzugt 0,5 bis 6,0 Gew.-%, gewählt, bezogen auf das Gesamtgewicht der Zubereitungen, falls die Gegenwart dieser Substanzen erwünscht ist. The total amount of all (single and multiple sulfonated) water-soluble UV Filter substances in the finished cosmetic or dermatological preparations, for example on phenylene-bis-benzimidazyl-tetrasulfonic acid disodium salt or their salts and / or the corresponding disulfonic acid or their salts and / or 2-phenylbenzimidazole-5-sulfonic acid or its salts and / or 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid or its salts and / or 4- (2-oxo-3-bornylidenemethyl) benzenesulfonic acid or its salts and / or 2-methyl-5- (2-oxo-3- bornylidene-methyl) -benzenesulfonic acid or its salts and / or benzene-1,4-di- (2- oxo-3-bornylidenemethyl) -10-sulfonic acid or its salts, is advantageously obtained from the Range from 0.1 to 10.0% by weight, preferably 0.5 to 6.0% by weight, selected on the total weight of the preparations, if the presence of these substances is desired.
Die Gesamtmenge an öllöslichen UV-Filtersubstanzen in den fertigen kosmetischen oder dermatologischen Zubereitungen, beispielsweise an 4,4',4"-(1,3,5-Triazin- 2,4,6-triyltriimino)-tris-benzoesäure-tris-(2-ethylhexylester) und/oder 4-tert.-Butyl- 4'-methoxy-dibenzoylmethan und/oder 4-Methylbenzylidencampher und/oder Octyldimethyl-p-Aminobenzoesäure und/oder Mexoryl®XL und/oder Uvasorb®HEB und/oder Tinosorb®S und/oder Benzophenon-3 und/oder Parsol®SLX und/oder Neo Heliopan®MA wird vorteilhaft aus dem Bereich von 0,1 bis 10,0 Gew.-%, bevorzugt 0,5 bis 6,0 Gew.-%, gewählt, bezogen auf das Gesamtgewicht der Zubereitungen, falls die Gegenwart dieser Substanzen erwünscht ist. The total amount of oil-soluble UV filter substances in the finished cosmetic or dermatological preparations, for example on 4,4 ', 4 "- (1,3,5-triazine 2,4,6-triyltriimino) tris-benzoic acid tris (2-ethylhexyl ester) and / or 4-tert-butyl 4'-methoxy-dibenzoylmethane and / or 4-methylbenzylidene camphor and / or Octyldimethyl-p-aminobenzoic acid and / or Mexoryl®XL and / or Uvasorb®HEB and / or Tinosorb®S and / or benzophenone-3 and / or Parsol®SLX and / or Neo Heliopan®MA is advantageously preferred in the range from 0.1 to 10.0% by weight 0.5 to 6.0% by weight, selected, based on the total weight of the preparations, if the presence of these substances is desired.
Die Gesamtmenge an 2-Ethylhexyl-p-methoxy-cinnamaten und/oder p-Methoxyzimtsäureisoamylester in den fertigen kosmetischen oder dermatologischen Zubereitungen wird vorteilhaft aus dem Bereich von 0,1 bis 15,0 Gew.-%, bevorzugt 0,5 bis 7,5 Gew.-%, gewählt, bezogen auf das Gesamtgewicht der Zubereitungen, falls die Gegenwart dieser Substanzen erwünscht ist. The total amount of 2-ethylhexyl-p-methoxy-cinnamate and / or p-Methoxycinnamic acid isoamyl ester in the finished cosmetic or dermatological Preparations from the range from 0.1 to 15.0% by weight are preferred 0.5 to 7.5% by weight, selected, based on the total weight of the preparations, if the presence of these substances is desired.
Die Gesamtmenge an Ethylhexyl-2-cyano-3,3-diphenylacrylat in den fertigen kosmetischen oder dermatologischen Zubereitungen wird, falls die Gegenwart dieser Substanz erwünscht ist, vorteilhaft aus dem Bereich von 0,1 bis 15,0 Gew.-%, bevorzugt 0,5 bis 10,0 Gew.-%, gewählt, bezogen auf das Gesamtgewicht der Zubereitungen. The total amount of ethylhexyl-2-cyano-3,3-diphenylacrylate in the finished cosmetic or dermatological preparations, if the presence of these Substance is desired, advantageously in the range from 0.1 to 15.0% by weight, preferably 0.5 to 10.0% by weight, selected, based on the total weight of the Preparations.
Die Gesamtmenge an einem oder mehreren Salicylsäurederivaten in den fertigen kosmetischen oder dermatologischen Zubereitungen wird vorteilhaft aus dem Bereich von 0,1 bis 15,0 Gew.-%, bevorzugt 0,5 bis 10,0 Gew.-%, gewählt, bezogen auf das Gesamtgewicht der Zubereitungen. Wenn Ethylhexylsalicylat gewählt wird, ist es von Vorteil, dessen Gesamtmenge aus dem Bereich von 0,1 bis 5,0 Gew.-% zu wählen. Wenn Homomenthylsalat gewählt wird, ist es von Vorteil, dessen Gesamtmenge aus dem Bereich von 0,1 bis 10,0 Gew.-% zu wählen. The total amount of one or more salicylic acid derivatives in the finished Cosmetic or dermatological preparations are advantageous from the field from 0.1 to 15.0% by weight, preferably 0.5 to 10.0% by weight, based on the Total weight of the preparations. If ethylhexyl salicylate is chosen, it is advantageous, the total amount of which ranges from 0.1 to 5.0% by weight choose. If homomenthyl salad is chosen, it is advantageous to Total amount to choose from the range of 0.1 to 10.0 wt .-%.
Weiterhin lassen sich die erfindungsgemäßen Acrylnitril-Derivate der Formel (I) auch mit UV-Absorbern, die für den technischen Produktschutz eingesetzt werden, kombinieren. Beispiele solcher UV-Absorber entsprechen vorwiegend Verbindungen aus der Reihe der Benzotriazole, Benzophenone und Malonsäureester. Furthermore, the acrylonitrile derivatives of the formula (I) according to the invention also with UV absorbers, which are used for technical product protection, combine. Examples of such UV absorbers mainly correspond to compounds from the series of benzotriazoles, benzophenones and malonic esters.
Die nachfolgenden Beispiele sollen die vorliegende Erfindung verdeutlichen, ohne sie einzuschränken. Alle Mengenangaben, Anteile und Prozentanteile sind, soweit nicht anders angegeben, auf das Gewicht und die Gesamtmenge bzw. auf das Gesamtgewicht der Zubereitungen bezogen. The following examples are intended to illustrate the present invention without restrict them. All quantities, proportions and percentages are so far not otherwise specified, on the weight and the total amount or on the Total weight of the preparations related.
Soweit nicht anders angegeben, erfolgte die Trennung oder Reinigung der Acrylnitril-Derivate per Kristallisation, Destillation oder Säulenchromatographie an Kieselgel 60 (Elution mit n-Hexan/Essigsäureethylester = (5 - 10) : 1). Unless otherwise stated, the separation or cleaning of the Acrylonitrile derivatives by crystallization, distillation or column chromatography Kieselgel 60 (elution with n-hexane / ethyl acetate = (5 - 10): 1).
Eine Mischung aus 0,5 Mol Orthocarbonsäureester, 0,5 Mol Cyanessigsäurealkylester und 0,5 Mol der entsprechenden NH-heterocyclischen Verbindung wird 2-3 Stunden auf 120°C erhitzt und der sich abspaltende Alkohol abdestilliert. Der anfallende Rückstand wird durch Kristallisation, Destillation oder Säulenchromatographie gereinigt. A mixture of 0.5 moles of orthocarboxylic acid ester, 0.5 moles Alkyl cyanoacetate and 0.5 mol of the corresponding NH heterocyclic compound Heated to 120 ° C for 2-3 hours and the alcohol which split off was distilled off. The accumulating residue is by crystallization, distillation or Column chromatography cleaned.
Eine Mischung aus 0,5 Mol Orthocarbonsäureester, 0,5 Mol Pivaloylacetonitril und
0,5 Mol der entsprechenden NH-heterocyclischen Verbindung wird 2-3 Stunden auf
120°C erhitzt und der sich abspaltende Alkohol abdestilliert. Der anfallende
Rückstand wird durch Kristallisation, Destillation oder Säulenchromatographie gereinigt.
Tabelle 1
Beispiel 13
Sonnenschutz Soft Creme (O/W), wasserfest
Herstellungsverfahren
Teil A: Auf ca. 85°C erhitzen.
Teil B: Rohstoffe ohne Carbopol einwiegen. Carbopol mit Ultra Turrax
eindispergieren. Auf ca. 85°C erhitzen. B zu A geben.
Teil C: Sofort zu A/B geben und anschließend heiß homogenisieren (Ultra
Turrax).
Unter Rühren abkühlen lassen.
Teil D: Zugeben und verrühren. Beispiel 14
Sonnenschutzlotion (O/W)
Herstellungsverfahren
Teil A: Auf ca. 85°C erhitzen.
Teil B: Rohstoffe ohne Carbopol einwiegen. Carbopol mit Ultra Turrax
eindispergieren. Auf ca. 85°C erhitzen. B zu A geben.
Teil C: Sofort zu A/B geben und anschließend heiß homogenisieren (Ultra
Turrax). Unter Rühren abkühlen lassen.
Teil D: Zugeben und verrühren. Beispiel 15
Sonnenschutzmilch (O/W)
Herstellungsverfahren
Teil A: Auf 80-85°C erhitzen.
Teil B: Auf 80-85°C erhitzen, unter Rühren Teil B zu Teil A geben.
Teil C: Carbopol in das Wasser eindispergieren und unter Rühren mit NaOH
neutralisieren.
Teil C bei ca. 60°C unter Rühren zugeben. Auf RT abkühlen lassen.
Teil D: Zugeben und verrühren. Beispiel 16
Sonnenschutzlotion (O/W)
Herstellungsverfahren
Teil A: Auf 80-85°C erhitzen.
Teil B: Auf 80-85°C erhitzen, unter Rühren Teil B zu Teil A geben.
Teil C: Carbopol in das Wasser eindispergieren und unter Rühren mit NaOH
neutralisieren.
Teil C bei ca. 60°C unter Rühren zugeben. Auf RT abkühlen lassen.
Teil D: Zugeben und verrühren. Beispiel 17
Sonnenschutzlotion (O/W)
Herstellungsverfahren
Teil A: UV-Absorber gemäß Formel 1 in den Ölen bzw flüssigen UV-Filtern
lösen (Erwärmen bis ca. 70°C). Abkühlen lasen auf ca. 30°C, restliche
Bestandteile außer Carbopol und Pemulen zufügen und bei
Raumtemperatur mischen (ca. 5 Minuten rühren). Carbopol und Pemulen
einrühren.
Teil B: Solbrole unter Erwärmen in Phenoxyethanol lösen. Mit Wasser und
Glycerin mischen, unter
Rühren zu Teil A geben. Ca. 60 Minuten rühren.
Teil C: Zu A/B geben, mit dem Ultra Turrax homogenisieren. Beispiel 18
Sonnenschutzcreme (W/O), wasserfest
Herstellungsverfahren
Teil A: Auf ca. 85°C erhitzen.
Teil B: Auf ca. 85°C erhitzen (ohne Zinkoxid; Zinkoxid mit dem Ultra Turrax
eindispergieren). B zu A geben.
Unter Rühren abkühlen lassen, anschließend homogenisieren. Beispiel 19
Sonnenschutz Softcreme (W/O)
Herstellungsverfahren
Teil A: Auf ca. 85°C erhitzen.
Teil B: Auf ca. 85°C erhitzen (ohne Zinkoxid; Zinkoxid mit dem Ultra Turrax
eindispergieren). B zu A geben. Unter Rühren abkühlen lassen.
Teil C: Zugeben und anschließend homogenisieren Beispiel 20
Sonnenschutzmilch (W/O)
Herstellungsverfahren
Teil A: Auf ca. 85°C erhitzen.
Teil B: Auf ca. 85°C erhitzen. B zu A geben. Unter Rühren abkühlen lassen.
Teil C: Zugeben und anschließend homogenisieren. Beispiel 21
Tagespflegecreme mit UV-Schutz
Herstellungsverfahren
Teil A: Auf 80°C erhitzen.
Teil B: Auf 80°C erhitzen. Unter Rühren zu Teil A geben.
Teil C: Carbopol in Wasser dispergieren und mit Natronlauge neutralisieren.
Bei ca. 55°C zu Teil A/B geben.
Teil D: Bei RT zugeben und homogenisieren. Beispiel 22
Sonnenschutzspray
Herstellungsverfahren
Teil A: Lara Care A-200 unter Rühren in den anderen Bestandteilen von Teil
A lösen.
Teil B: Alle Rohstoffe (ohne Pemulen) einwiegen und die kristallinen Sub
unter Erwärmen lösen. Pemulen eindispergieren. Teil B zu Teil A
geben und 1 Minute homogenisieren.
Teil C + D zugeben und nochmals 1-2 Minuten mit dem Ultra Turrax homogenisieren. Beispiel 23
Sonnenschutz Hydrodispersionsgel (Balm)
Herstellungsverfahren
Teil A: Carbopol in Wasser dispergieren und mit Natronlauge neutralisieren.
Teil B: Unter Rühren zu Teil A geben.
Teil C: Kristalline Bestandteile unter Erwärmen (max. 40°C) in den anderen
Rohstoffen von Teil C lösen und zu Teil A/B geben. Gut verrühren
und anschließend homogenisieren (Hormozenta). Beispiel 24
Hair Conditioner mit UV-Filtern
Herstellungsverfahren
Teil A: Auf 80°C erhitzen.
Teil B: Auf 80°C erhitzen. Unter Rühren zu Teil A geben.
Teil C: Bei 40°C zugeben und auf RT abkühlen.
A mixture of 0.5 mol of orthocarboxylic acid ester, 0.5 mol of pivaloylacetonitrile and 0.5 mol of the corresponding NH-heterocyclic compound is heated to 120 ° C. for 2-3 hours and the alcohol which is split off is distilled off. The residue obtained is purified by crystallization, distillation or column chromatography. Table 1
Example 13 Sun protection soft cream (O / W), waterproof
Manufacturing process part A: Heat to approx. 85 ° C.
Part B: Weigh raw materials without Carbopol. Disperse Carbopol with Ultra Turrax. Heat to approx. 85 ° C. Add B to A.
Part C: Add immediately to A / B and then homogenize hot (Ultra Turrax).
Let cool while stirring.
Part D: Add and stir. Example 14 Sun Protection Lotion (O / W)
Manufacturing process part A: Heat to approx. 85 ° C.
Part B: Weigh raw materials without Carbopol. Disperse Carbopol with Ultra Turrax. Heat to approx. 85 ° C. Add B to A.
Part C: Add immediately to A / B and then homogenize hot (Ultra Turrax). Let cool while stirring.
Part D: Add and stir. Example 15 Sun protection milk (O / W)
Manufacturing Process Part A: Heat to 80-85 ° C.
Part B: Heat to 80-85 ° C, add Part B to Part A while stirring.
Part C: Disperse Carbopol in the water and neutralize with NaOH while stirring.
Add part C at approx. 60 ° C while stirring. Let cool to RT.
Part D: Add and stir. Example 16 Sun Protection Lotion (O / W)
Manufacturing Process Part A: Heat to 80-85 ° C.
Part B: Heat to 80-85 ° C, add Part B to Part A while stirring.
Part C: Disperse Carbopol in the water and neutralize with NaOH while stirring.
Add part C at approx. 60 ° C while stirring. Let cool to RT.
Part D: Add and stir. Example 17 Sunscreen Lotion (O / W)
Manufacturing process part A: Dissolve UV absorber according to formula 1 in the oils or liquid UV filters (heating up to approx. 70 ° C). Allow to cool to approx. 30 ° C, add the remaining ingredients except Carbopol and Pemulen and mix at room temperature (stir for approx. 5 minutes). Stir in the Carbopol and Pemulen.
Part B: Dissolve Solbrole in phenoxyethanol while heating. Mix with water and glycerin, add to part A while stirring. Approximately Stir for 60 minutes.
Part C: Add to A / B, homogenize with the Ultra Turrax. Example 18 Sun protection cream (W / O), waterproof
Manufacturing process part A: Heat to approx. 85 ° C.
Part B: Heat to approx. 85 ° C (without zinc oxide; disperse zinc oxide with the Ultra Turrax). Add B to A.
Allow to cool with stirring, then homogenize. Example 19 Sun protection soft cream (W / O)
Manufacturing process part A: Heat to approx. 85 ° C.
Part B: Heat to approx. 85 ° C (without zinc oxide; disperse zinc oxide with the Ultra Turrax). Add B to A. Let cool while stirring.
Part C: Add and then homogenize Example 20 Sun protection milk (W / O)
Manufacturing process part A: Heat to approx. 85 ° C.
Part B: Heat to approx. 85 ° C. Add B to A. Let cool while stirring.
Part C: Add and then homogenize. Example 21 Day care cream with UV protection
Manufacturing Process Part A: Heat to 80 ° C.
Part B: Heat to 80 ° C. Add to part A while stirring.
Part C: Disperse Carbopol in water and neutralize with sodium hydroxide solution.
Add to part A / B at approx. 55 ° C.
Part D: Add at RT and homogenize. Example 22 Sunscreen Spray
Manufacturing Process Part A: Dissolve Lara Care A-200 in the other ingredients of Part A while stirring.
Part B: Weigh in all raw materials (without Pemulen) and dissolve the crystalline sub with heating. Disperse the pemules. Add part B to part A and homogenize for 1 minute.
Add part C + D and homogenize again with the Ultra Turrax for 1-2 minutes. Example 23 Sun Protection Hydrodispersion Gel (Balm)
Manufacturing process Part A: Disperse Carbopol in water and neutralize with sodium hydroxide solution.
Part B: Add to Part A while stirring.
Part C: Dissolve crystalline constituents from part C while heating (max. 40 ° C) in the other raw materials and add to part A / B. Mix well and then homogenize (hormocenta). Example 24 Hair Conditioner with UV Filters
Manufacturing Process Part A: Heat to 80 ° C.
Part B: Heat to 80 ° C. Add to part A while stirring.
Part C: Add at 40 ° C and cool to RT.
Von einer 5%igen Lösung des zu prüfenden UV-Filters bzw. einer Kombination mit
anderen marktüblichen UV-Absorbern wie OMC (Octylmethoxycinnamat) und/oder
BMDM (tert.-Butyl-methoxy-dibenzoylmethan) werden 20 µl gleichmäßig auf
10 cm2 eines Glasplättchens mit aufgerauter Oberfläche gegeben. Nach einer
Aufbewahrungszeit von 30 Minuten im Dunkeln wird die Probe in einem Suntest-Gerät
mit einem Solarstandardfilter und Globalsensor 140 Minuten mit einer
Bestrahlungsstärke von 765 W/m2 bestrahlt. Während der Bestrahlung befinden sich die
Glasplättchen auf dem gekühlten Boden des Suntestgerätes. Insgesamt werden 4
Glasplättchen gleichzeitig bestrahlt. Nach dem Bestrahlungsende werden die Proben
mit Ethanol von den Glasplättchen in einen 25 ml Messkolben gespült. In den so
erhaltenen Proben wird der Gehalt an Lichtschutzmittel mittels Photometer oder
HPLC bestimmt. Parallel werden Blindproben wie oben angegeben auf die
Glasplättchen aufgetragen und anschließend wie die bestrahlten Proben abgespült und
vermessen.
Tabelle 2
From a 5% solution of the UV filter to be tested or a combination with other commercially available UV absorbers such as OMC (octyl methoxy cinnamate) and / or BMDM (tert-butyl methoxy dibenzoyl methane), 20 µl are uniformly spread over 10 cm 2 Glass plate with a roughened surface. After a storage period of 30 minutes in the dark, the sample is irradiated in a Suntest device with a solar standard filter and global sensor for 140 minutes with an irradiance of 765 W / m 2 . During the irradiation, the glass plates are on the cooled bottom of the sun tester. A total of 4 glass plates are irradiated at the same time. After the end of irradiation, the samples are rinsed with ethanol from the glass plates into a 25 ml volumetric flask. The content of light stabilizer in the samples thus obtained is determined by means of a photometer or HPLC. In parallel, blank samples are applied to the glass platelets as described above and then rinsed and measured like the irradiated samples. Table 2
Claims (20)
worin
R1 Wasserstoff, C1-C20-Alkyl, C2-C20-Alkenyl, C2-C20-Alkinyl, C6-C12- Aryl bedeuten kann,
R2 COOR13, COR13, CONR13R14, CN,
wobei R13-R14 für Wasserstoff, C1-C20-Alkyl, C2-C20-Alkenyl oder C2-C20-Alkinyl, C6-C12-Aryl, C3-C15-Cycloalkyl, C5-C12-Heteroaryl steht, die gegebenenfalls durch Amino, Hydroxy, Acetoxy, Carboxy, Carbalkoxy, Carbamoyl, eine Gruppe W substituiert oder durch Ether- Sauerstoff unterbrochen sein können,
R3-R12 die unter R1 angegebene Bedeutung haben oder auch C3-C15- Cycloalkyl, C5-C12-Heteroaryl, C1-C16-Alkoxy, C6-C12-Aryloxy, Amino, Hydroxy, Acetoxy, Carboxy, Carbalkoxy, Carbamoyl bedeuten, wobei sie mit einer Gruppe W substituiert oder durch Ether- Sauerstoff unterbrochen sein können,
mit der Maßgabe, dass auch zwei Substituenten von R3-R12 an benachbarten C-Atomen zusammen eine gegebenenfalls substituierte C1-C4-Alkylengruppe bedeuten können, wobei eine Methylengruppe durch -O-, -S- oder NH- ersetzt sein kann,
z 0, 1 oder 2
W Silane, Oligosilane und Polysiloxane der allgemeinen Formeln WI bis WIII
WI SiR15 a(OSiR15 3)b
a 0, 1, 2 oder 3
b 3, 2, 1 oder 0
a + b 3
A eine Bindung zum Nachbaratom
c 1-10
R15 ein offenkettiger oder verzweigter aliphatischer, araliphatischer, cycloaliphatischer oder gegebenenfalls substituierter aromatischer Rest mit jeweils bis zu 18 C-Atomen
bedeuten. 1. light protection preparations containing acrylonitrile derivatives of the formula (I) in which the C = C double bond is in the E or Z configuration,
wherein
R 1 can denote hydrogen, C 1 -C 20 alkyl, C 2 -C 20 alkenyl, C 2 -C 20 alkynyl, C 6 -C 12 aryl,
R 2 COOR 13 , COR 13 , CONR 13 R 14 , CN,
where R 13 -R 14 is hydrogen, C 1 -C 20 alkyl, C 2 -C 20 alkenyl or C 2 -C 20 alkynyl, C 6 -C 12 aryl, C 3 -C 15 cycloalkyl, C 5 -C 12 heteroaryl, which may optionally be substituted by amino, hydroxy, acetoxy, carboxy, carbalkoxy, carbamoyl, a group W or interrupted by ether oxygen,
R 3 -R 12 have the meaning given under R 1 or also C 3 -C 15 cycloalkyl, C 5 -C 12 heteroaryl, C 1 -C 16 alkoxy, C 6 -C 12 aryloxy, amino, hydroxy, Mean acetoxy, carboxy, carbalkoxy, carbamoyl, where they can be substituted by a group W or interrupted by ether oxygen,
with the proviso that two substituents of R 3 -R 12 on adjacent C atoms together can mean an optionally substituted C 1 -C 4 alkylene group, it being possible for a methylene group to be replaced by -O-, -S- or NH- .
z 0, 1 or 2
W silanes, oligosilanes and polysiloxanes of the general formulas W I to W III
W I SiR 15 a (OSiR 15 3 ) b
a 0, 1, 2 or 3
b 3, 2, 1 or 0
a + b 3
A is a bond to the neighboring atom
c 1-10
R 15 is an open-chain or branched aliphatic, araliphatic, cycloaliphatic or optionally substituted aromatic radical, each having up to 18 carbon atoms
mean.
worin
R1 Wasserstoff, C1-C12-Alkyl, C2-C12-Alkenyl, C2-C12-Alkinyl, Phenyl bedeuten kann,
R2 COOR13, COR13,
wobei R13 für Wasserstoff, C1-C12-Alkyl, C2-C12-Alkenyl, C2-C12- Alkinyl oder C6-C12-Alkyl steht, die gegebenenfalls durch Amino, Hydroxy, Acetoxy, Carboxy, Carbalkoxy, Carbamoyl, eine Gruppe W substituiert oder durch Ether-Sauerstoff unterbrochen sein können,
R3-R12 die unter R1 angegebene Bedeutung haben oder auch C3-C15- Cycloalkyl, C5-C12-Heteroaryl, C1-C16-Alkoxy, C6-C12-Aryloxy, Amino, Hydroxy, Acetoxy, Carboxy, Carbalkoxy, Carbamoyl bedeuten, wobei sie mit einer Gruppe W substituiert oder durch Ether- Sauerstoff unterbrochen sein können,
mit der Maßgabe, dass auch zwei Substituenten von R3-R12 an benachbarten C-Atomen zusammen eine gegebenenfalls substituierte C1-C4-Alkylengruppe bedeuten können, und
z 0, 1 oder 2 bedeutet. 2. Light protection preparations according to claim 1 containing compounds of the formula (IA)
wherein
R 1 can be hydrogen, C 1 -C 12 alkyl, C 2 -C 12 alkenyl, C 2 -C 12 alkynyl, phenyl,
R 2 COOR 13 , COR 13 ,
where R 13 is hydrogen, C 1 -C 12 alkyl, C 2 -C 12 alkenyl, C 2 -C 12 alkynyl or C 6 -C 12 alkyl, which may be replaced by amino, hydroxy, acetoxy, carboxy, Carbalkoxy, carbamoyl, a group W substituted or interrupted by ether oxygen,
R 3 -R 12 have the meaning given under R 1 or also C 3 -C 15 cycloalkyl, C 5 -C 12 heteroaryl, C 1 -C 16 alkoxy, C 6 -C 12 aryloxy, amino, hydroxy, Mean acetoxy, carboxy, carbalkoxy, carbamoyl, where they can be substituted by a group W or interrupted by ether oxygen,
with the proviso that two substituents of R 3 -R 12 on adjacent C atoms together can mean an optionally substituted C 1 -C 4 alkylene group, and
z means 0, 1 or 2.
worin
R1 Wasserstoff, C1-C6-Alkyl, Phenyl bedeuten kann,
R3-R12 Wasserstoff, C1-C12-Alkyl, C2-C12-Alkenyl, C2-C12-Alkinyl, Phenyl, C1-C12-Alkoxy, Hydroxy, Acetoxy, Carboxy, Carbalkoxy, Carbamoyl bedeuten können, wobei sie mit einer Gruppe W substituiert oder durch Ether-Sauerstoff unterbrochen sein können,
mit der Maßgabe, dass auch zwei Substituenten von R3-R8 an benachbarten C-Atomen zusammen eine gegebenenfalls substituierte C1-C4-Alkylengruppe bedeuten können
R16-R18 unabhängig voneinander Wasserstoff, C1-C12-Alkyl, C2-C12-Alkenyl, C2-C12-Alkinyl, bedeuten können, wobei diese mit C1-C12-Alkoxy, Hydroxy, Acetoxy, Carboxy, Carbalkoxy, Carbamoyl, einer Gruppe W substituiert oder durch Ether-Sauerstoff unterbrochen sein können,
z 0, 1 oder 2 bedeutet. 3. Light protection preparations according to claim 1 or 2 containing compounds of the formula (IB)
wherein
R 1 can denote hydrogen, C 1 -C 6 alkyl, phenyl,
R 3 -R 12 hydrogen, C 1 -C 12 alkyl, C 2 -C 12 alkenyl, C 2 -C 12 alkynyl, phenyl, C 1 -C 12 alkoxy, hydroxy, acetoxy, carboxy, carbalkoxy, carbamoyl can mean, where they can be substituted by a group W or interrupted by ether oxygen,
with the proviso that two substituents of R 3 -R 8 on adjacent C atoms together can mean an optionally substituted C 1 -C 4 alkylene group
R 16 -R 18 independently of one another can be hydrogen, C 1 -C 12 alkyl, C 2 -C 12 alkenyl, C 2 -C 12 alkynyl, these with C 1 -C 12 alkoxy, hydroxy, acetoxy , Carboxy, carbalkoxy, carbamoyl, a group W substituted or interrupted by ether oxygen,
z means 0, 1 or 2.
2-[(2,3-Dihydro-1H-indol-1-yl)methylen]-4,4-dimethyl-3-oxo-pentannitril, 2- [(2,3-Dihydro-2-methyl-1H-indol-1-yl)methylen]-4,4-dimethyl-3-oxo-pentannitril, 2-[(2,3-Dihydro-5-methyl-1H-indol-1-yl)methylen]-4,4-dimethyl-3- oxo-pentannitril,
2-[(2,3-Dihydro-2,3-dimethyl-1H-indol-1-yl)methylen]-4,4-dimethyl-3-oxo- pentannitril, 2-[(2,3-Dihydro-2,5-dimethyl-1H-indol-1-yl)methylen]-4,4- dimethyl-3-oxo-pentannitril, 2-[(2,3-Dihydro-2,3,3-trimethyl-1H-indol-1- yl)methylen]-4,4-dimethyl-3-oxo-pentannitril, 2-[(2,3-Dihydro-5-methoxy- 1H-indol-1-yl)methylen]-4,4-dimethyl-3-oxo-pentannitril, 2-[(2,3-Dihydro-2- methyl-5-methoxy-1H-indol-1-yl)methylen]-4,4-dimethyl-3-oxo-pentannitril, 2-[(2,3-Dihydro-2,3,3-trimethyl-5-methoxy-1H-indol-1-yl)methylen]-4,4-dimethyl-3-oxo-pentannitril, 2-[1-(2,3-Dihydro-2-methyl-1H-indol-1-yl)ethyliden]-4,4-dimethyl-3-oxo-pentannitril, 2-[1-(3,4-Dihydro-1(2H)-quinolinyl)methylen]-4,4-dimethyl-3-oxo-pentannitril,2-[1-(3,4-Dihydro-1(2H)- quinolinyl)ethyliden]-4,4-dimethyl-3-oxo-pentannitril,2-[(1,2,3,4,10,11-Hexahydro-9H-carbazol-9-yl)methylen]-4,4-dimethyl-3-oxo-pentannitril. 19. Compounds from the group of 3-oxo-4,4-dimethyl-pentanenitriles from the series
2 - [(2,3-Dihydro-1H-indol-1-yl) methylene] -4,4-dimethyl-3-oxopentanenitrile, 2- [(2,3-dihydro-2-methyl-1H-indole -1-yl) methylene] -4,4-dimethyl-3-oxopentanenitrile, 2 - [(2,3-dihydro-5-methyl-1H-indol-1-yl) methylene] -4,4-dimethyl -3- oxo-pentonitrile,
2 - [(2,3-dihydro-2,3-dimethyl-1H-indol-1-yl) methylene] -4,4-dimethyl-3-oxopentanenitrile, 2 - [(2,3-dihydro-2 , 5-dimethyl-1H-indol-1-yl) methylene] -4,4-dimethyl-3-oxopentanenitrile, 2 - [(2,3-dihydro-2,3,3-trimethyl-1H-indole- 1-yl) methylene] -4,4-dimethyl-3-oxopentanenitrile, 2 - [(2,3-dihydro-5-methoxy-1H-indol-1-yl) methylene] -4,4-dimethyl- 3-oxopentanenitrile, 2 - [(2,3-dihydro-2-methyl-5-methoxy-1H-indol-1-yl) methylene] -4,4-dimethyl-3-oxopentanenitrile, 2- [ (2,3-dihydro-2,3,3-trimethyl-5-methoxy-1H-indol-1-yl) methylene] -4,4-dimethyl-3-oxopentanenitrile, 2- [1- (2, 3-dihydro-2-methyl-1H-indol-1-yl) ethylidene] -4,4-dimethyl-3-oxopentanenitrile, 2- [1- (3,4-dihydro-1 (2H) -quinolinyl) methylene] -4,4-dimethyl-3-oxopentanenitrile, 2- [1- (3,4-dihydro-1 (2H) - quinolinyl) ethylidene] -4,4-dimethyl-3-oxopentanenitrile, 2 - [(1,2,3,4,10,11-hexahydro-9H-carbazol-9-yl) methylene] -4,4-dimethyl-3-oxo-pentanenitrile.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2002119433 DE10219433A1 (en) | 2002-05-02 | 2002-05-02 | Sunscreen preparations using acrylonitrile derivatives |
PCT/EP2003/004479 WO2003092643A1 (en) | 2002-05-02 | 2003-04-30 | Light-protection formulations using acrylonitrile derivatives |
AU2003224139A AU2003224139A1 (en) | 2002-05-02 | 2003-04-30 | Light-protection formulations using acrylonitrile derivatives |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2002119433 DE10219433A1 (en) | 2002-05-02 | 2002-05-02 | Sunscreen preparations using acrylonitrile derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
DE10219433A1 true DE10219433A1 (en) | 2003-11-20 |
Family
ID=29264954
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE2002119433 Withdrawn DE10219433A1 (en) | 2002-05-02 | 2002-05-02 | Sunscreen preparations using acrylonitrile derivatives |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003224139A1 (en) |
DE (1) | DE10219433A1 (en) |
WO (1) | WO2003092643A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1688127A1 (en) * | 2005-01-18 | 2006-08-09 | L'oreal | Hair treatment composition containing an aromatic alcohol, an aromatic carboxylic acid a protecting agent |
WO2011101250A1 (en) * | 2010-02-17 | 2011-08-25 | Beiersdorf Ag | Use of substances to improve the removability of uv filter stains on textiles by washing |
US8790623B2 (en) | 2005-01-18 | 2014-07-29 | Il'Oreal | Composition for treating keratin fibers, comprising at least one aromatic alcohol, at least one aromatic carboxylic acid, and at least one protecting agent |
EP1676562B2 (en) † | 2004-12-16 | 2016-03-02 | Kao Germany GmbH | Composition for the hair containing uv filters |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2939710B1 (en) * | 2014-04-29 | 2020-06-17 | Symrise AG | Active Mixtures |
KR20180097443A (en) * | 2015-12-23 | 2018-08-31 | 커먼웰쓰 사이언티픽 앤 인더스트리알 리서치 오거니제이션 | Compounds |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1538374A (en) * | 1966-06-15 | 1968-09-06 | Bayer Ag | New ultraviolet light absorbers |
DE19539623A1 (en) * | 1995-10-16 | 1997-04-17 | Haarmann & Reimer Gmbh | Sulphonic acids, process for their preparation and their use as UV absorbers |
-
2002
- 2002-05-02 DE DE2002119433 patent/DE10219433A1/en not_active Withdrawn
-
2003
- 2003-04-30 AU AU2003224139A patent/AU2003224139A1/en not_active Abandoned
- 2003-04-30 WO PCT/EP2003/004479 patent/WO2003092643A1/en not_active Application Discontinuation
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1676562B2 (en) † | 2004-12-16 | 2016-03-02 | Kao Germany GmbH | Composition for the hair containing uv filters |
EP1688127A1 (en) * | 2005-01-18 | 2006-08-09 | L'oreal | Hair treatment composition containing an aromatic alcohol, an aromatic carboxylic acid a protecting agent |
US8790623B2 (en) | 2005-01-18 | 2014-07-29 | Il'Oreal | Composition for treating keratin fibers, comprising at least one aromatic alcohol, at least one aromatic carboxylic acid, and at least one protecting agent |
WO2011101250A1 (en) * | 2010-02-17 | 2011-08-25 | Beiersdorf Ag | Use of substances to improve the removability of uv filter stains on textiles by washing |
Also Published As
Publication number | Publication date |
---|---|
AU2003224139A1 (en) | 2003-11-17 |
WO2003092643A1 (en) | 2003-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1341752B1 (en) | Novel indanylidene compounds | |
EP1748753B1 (en) | BENZYLIDENEN-ßDICARBONYL COMPOUNDS AS NOVEL UV-ABSORBERS | |
KR101737662B1 (en) | 2-phenyl-1,2,3-benzotriazoles for uv radiation absorbance | |
DE60307234T2 (en) | SUNSCREEN COMPOSITIONS AND DIHYDROPYRIDINE AND DIHYDROPYRANEES | |
WO2006015954A1 (en) | Alpha-benzoyl-cinnamic acid nitrile as novel uv-absorbers | |
EP0823418B1 (en) | Indanylidene derivatives and their use as UV-absorbers | |
DE10030663A1 (en) | UV-B filters | |
EP1129695A1 (en) | Cosmetic or dermatological sunscreen formulations | |
WO2004022015A1 (en) | Use of diketopiperazine derivatives as photostable uv-filters in cosmetic and pharmaceutical preparations | |
EP1060734B1 (en) | Use of cyclic enamines as sun protection agents | |
US20070219275A1 (en) | Use of Benzophenone Uv Filters for Preventing Tanning | |
DE10219433A1 (en) | Sunscreen preparations using acrylonitrile derivatives | |
EP0935959B1 (en) | Use of beeswax to increase the UVA protection factor of cosmetic or dermatologic sunscreens | |
DE10063867A1 (en) | Compositions for protecting human skin and hair against the damaging effects of ultraviolet radiation, comprise new or known N-substituted anilinomethylene malonic acid derivatives | |
EP1008593B1 (en) | Benzylidene-gamma-butyrolactones, process for their production and use thereof as UV absorbers | |
DE10206562A1 (en) | New benzazolyl-phenylaminomethylene-malonic acid derivatives, useful as ultraviolet absorbers and photostabilizers, especially in cosmetic, dermatological or pharmaceutical preparations | |
DE10009442A1 (en) | Cosmetic or dermatological compositions comprising a dibenzoylmethane derivative, useful as sunscreens, include a cycloalkyl 3,3-diphenylacrylate photostabilizer | |
DE19830461A1 (en) | Use of iron-titanium mixed oxides to enhance the sun protection performance of cosmetic or dermatological sunscreens | |
EP1311233A1 (en) | Substances for inducing and intensifying the tanning mechanisms of the skin and cosmetic or dermatological preparations which contain said substances | |
DE10214843A1 (en) | Light protection preparations with light-stable UV-A protection | |
DE10044351A1 (en) | Cosmetic or dermatological compositions comprising a dibenzoylmethane derivative, useful as sunscreens, include a cycloalkyl 3,3-diphenylacrylate photostabilizer | |
DE19719929A1 (en) | Use of propylene-glycol-di:caprylate-di:caprate | |
DE19748755A1 (en) | Stabilisation of di:benzoyl-methane ultraviolet filters | |
DE10218540A1 (en) | New crystalline modification B of 1-(4-t-butylphenyl)-3-(4-methoxyphenyl)-1,3-propane dione useful as an ultraviolet filter in cosmetic compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8139 | Disposal/non-payment of the annual fee |